| Year |
Citation |
Score |
| 2024 |
Kapelios CJ, Greene SJ, Mentz RJ, Ikeaba U, Wojdyla D, Anstrom KJ, Eisenstein EL, Pitt B, Velazquez EJ, Fang JC. Torsemide Versus Furosemide After Discharge in Patients Hospitalized With Heart Failure Across the Spectrum of Ejection Fraction: Findings From TRANSFORM-HF. Circulation. Heart Failure. e011246. PMID 38436075 DOI: 10.1161/CIRCHEARTFAILURE.123.011246 |
0.308 |
|
| 2023 |
Krim SR, Anand S, Greene SJ, Chen A, Wojdyla D, Vilaro J, Haught H, Herre JM, Eisenstein EL, Anstrom KJ, Pitt B, Velazquez EJ, Mentz RJ. Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure: A Substudy of the TRANSFORM-HF Randomized Clinical Trial. Jama Cardiology. PMID 37955908 DOI: 10.1001/jamacardio.2023.4776 |
0.308 |
|
| 2023 |
Chew DS, Li Y, Bigelow R, Cowper PA, Anstrom KJ, Daniels MR, Davidson-Ray L, Hernandez AF, O'Connor CM, Armstrong PW, Mark DB. Cost-Effectiveness of Vericiguat in Patients With Heart Failure With Reduced Ejection Fraction: The VICTORIA Randomized Clinical Trial. Circulation. PMID 37671551 DOI: 10.1161/CIRCULATIONAHA.122.063602 |
0.303 |
|
| 2023 |
Ezekowitz JA, McMullan CJ, Westerhout CM, Piña IL, Lopez-Sendon J, Anstrom KJ, Hernandez AF, Lam CSP, O'Connor CM, Pieske B, Ponikowski P, Roessig L, Voors AA, Koglin J, Armstrong PW, et al. Background Medical Therapy and Clinical Outcomes From the VICTORIA Trial. Circulation. Heart Failure. e010599. PMID 37417824 DOI: 10.1161/CIRCHEARTFAILURE.123.010599 |
0.322 |
|
| 2023 |
Greene SJ, Velazquez EJ, Anstrom KJ, Clare RM, DeWald TA, Psotka MA, Ambrosy AP, Stevens G, Rommel JJ, Alexy T, Ketema F, Kim DY, Desvigne-Nickens P, Pitt B, Eisenstein EL, et al. Effect of Torsemide vs Furosemide on Symptoms and Quality of Life Among Patients Hospitalized for Heart Failure: The TRANSFORM-HF Randomized Clinical Trial. Circulation. PMID 37212600 DOI: 10.1161/CIRCULATIONAHA.123.064842 |
0.331 |
|
| 2023 |
Wang TY, Wahed AS, Morris A, Kreuziger LB, Quigley JG, Lamas GA, Weissman AJ, Lopez-Sendon J, Knudson MM, Siegal DM, Kasthuri RS, Alexander AJ, Wahid L, Atassi B, Miller PJ, ... ... Anstrom KJ, et al. Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization. Annals of Internal Medicine. PMID 36940444 DOI: 10.7326/M22-3350 |
0.546 |
|
| 2023 |
Mentz RJ, Anstrom KJ, Eisenstein EL, Sapp S, Greene SJ, Morgan S, Testani JM, Harrington AH, Sachdev V, Ketema F, Kim DY, Desvigne-Nickens P, Pitt B, Velazquez EJ. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial. Jama. 329: 214-223. PMID 36648467 DOI: 10.1001/jama.2022.23924 |
0.319 |
|
| 2022 |
Butler J, Usman MS, Anstrom KJ, Blaustein RO, Bonaca MP, Ezekowitz JA, Freitas C, Lam CS, Lewis EF, Lindenfeld J, McMullan CJ, Mentz RJ, O'Connor C, Rosano GM, Saldarriaga CI, et al. Soluble Guanylate Cyclase Stimulators in Patients with Heart Failure with Reduced Ejection Fraction Across the Risk Spectrum. European Journal of Heart Failure. PMID 36250238 DOI: 10.1002/ejhf.2720 |
0.304 |
|
| 2022 |
Butler J, Stebbins A, Melenovský V, Sweitzer NK, Cowie MR, Stehlik J, Khan MS, Blaustein RO, Ezekowitz JA, Hernandez AF, Lam CSP, Nkulikiyinka R, O'Connor CM, Pieske BM, Ponikowski P, ... ... Anstrom KJ, et al. Vericiguat and Health-Related Quality of Life in Patients With Heart Failure With Reduced Ejection Fraction: Insights From the VICTORIA Trial. Circulation. Heart Failure. 101161CIRCHEARTFAILU. PMID 35656822 DOI: 10.1161/CIRCHEARTFAILURE.121.009337 |
0.306 |
|
| 2022 |
Butler J, Spertus JA, Bamber L, Khan MS, Roessig L, Vlajnic V, Norquist JM, Anstrom KJ, Blaustein RO, Lam CSP, Armstrong PW. Defining changes in physical limitation from the patient perspective: insights from the VITALITY-HFpEF randomized trial. European Journal of Heart Failure. PMID 35274420 DOI: 10.1002/ejhf.2481 |
0.311 |
|
| 2021 |
Luo N, O'Connor CM, Chiswell K, Anstrom KJ, Newby LK, Mentz RJ. Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction. Cjc Open. 3: 1333-1340. PMID 34901801 DOI: 10.1016/j.cjco.2021.06.007 |
0.324 |
|
| 2021 |
Mentz RJ, Mulder H, Mosterd A, Sweitzer NK, Senni M, Butler J, Ezekowitz JA, Lam CSP, Pieske B, Ponikowski P, Voors AA, Anstrom KJ, Armstrong PW, O'connor CM, Hernandez AF, et al. Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial. Journal of Cardiac Failure. PMID 34217593 DOI: 10.1016/j.cardfail.2021.05.016 |
0.304 |
|
| 2021 |
Mentz RJ, Mulder H, Mosterd A, Sweitzer NK, Senni M, Butler J, Ezekowitz JA, Lam CSP, Pieske B, Ponikowski P, Voors AA, Anstrom KJ, Armstrong PW, O'Connor CM. Clinical Outcome Predictions for the VerICiguaT Global Study in Subjects With Heart Failure With Reduced Ejection Fraction (VICTORIA) Trial: VICTORIA Outcomes Model. Journal of Cardiac Failure. PMID 34216757 DOI: 10.1016/j.cardfail.2021.05.016 |
0.308 |
|
| 2021 |
Greene SJ, Velazquez EJ, Anstrom KJ, Eisenstein EL, Sapp S, Morgan S, Harding T, Sachdev V, Ketema F, Kim DY, Desvigne-Nickens P, Pitt B, Mentz RJ. Pragmatic Design of Randomized Clinical Trials for Heart Failure: Rationale and Design of the TRANSFORM-HF Trial. Jacc. Heart Failure. PMID 33714745 DOI: 10.1016/j.jchf.2021.01.013 |
0.323 |
|
| 2020 |
Olsen CR, Mentz RJ, Anstrom KJ, Page D, Patel PA. Clinical applications of machine learning in the diagnosis, classification, and prediction of heart failure. American Heart Journal. 229: 1-17. PMID 32905873 DOI: 10.1016/J.Ahj.2020.07.009 |
0.301 |
|
| 2020 |
Poole JE, Olshansky B, Mark DB, Anderson J, Johnson G, Hellkamp AS, Davidson-Ray L, Fishbein DP, Boineau RE, Anstrom KJ, Reinhall PG, Packer DL, Lee KL, Bardy GH. Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT. Journal of the American College of Cardiology. 76: 405-415. PMID 32703511 DOI: 10.1016/J.Jacc.2020.05.061 |
0.407 |
|
| 2020 |
Jawitz OK, Wang TY, Lopes RD, Chavez A, Boyer B, Kim H, Anstrom KJ, Becker RC, Blackstone E, Ruel M, Thourani VH, Puskas JD, Gerdisch MW, Johnston D, Capps S, et al. Rationale and design of PROACT Xa: A randomized, multicenter, open-label, clinical trial to evaluate the efficacy and safety of apixaban versus warfarin in patients with a mechanical On-X Aortic Heart Valve. American Heart Journal. 227: 91-99. PMID 32693197 DOI: 10.1016/J.Ahj.2020.06.014 |
0.36 |
|
| 2020 |
Escolar E, Ujueta F, Kim H, Mark DB, Boineau R, Nahin RL, Goertz C, Lee KL, Anstrom KJ, Lamas GA. Possible differential benefits of edetate disodium in post-myocardial infarction patients with diabetes treated with different hypoglycemic strategies in the Trial to Assess Chelation Therapy (TACT). Journal of Diabetes and Its Complications. 107616. PMID 32446881 DOI: 10.1016/J.Jdiacomp.2020.107616 |
0.366 |
|
| 2020 |
Fanaroff AC, Peterson ED, Kaltenbach LA, Anstrom KJ, Fonarow GC, Henry TD, Cannon CP, Choudhry NK, Cohen DJ, Atreja N, Bhalla N, Eudicone JM, Wang TY. Copayment Reduction Voucher Utilization and Associations With Medication Persistence and Clinical Outcomes: Findings From the ARTEMIS Trial. Circulation. Cardiovascular Quality and Outcomes. CIRCOUTCOMES11900618. PMID 32393129 DOI: 10.1161/Circoutcomes.119.006182 |
0.322 |
|
| 2020 |
Fiuzat M, Ezekowitz J, Alemayehu W, Westerhout CM, Sbolli M, Cani D, Whellan DJ, Ahmad T, Adams K, Piña IL, Patel CB, Anstrom KJ, Cooper LS, Mark D, Leifer ES, et al. Assessment of Limitations to Optimization of Guideline-Directed Medical Therapy in Heart Failure From the GUIDE-IT Trial: A Secondary Analysis of a Randomized Clinical Trial. Jama Cardiology. PMID 32319999 DOI: 10.1001/Jamacardio.2020.0640 |
0.421 |
|
| 2020 |
Doll JA, Kaltenbach LA, Anstrom KJ, Cannon CP, Henry TD, Fonarow GC, Choudhry NK, Fonseca E, Bhalla N, Eudicone JM, Peterson ED, Wang TY. Impact of a Copayment Reduction Intervention on Medication Persistence and Cardiovascular Events in Hospitals With and Without Prior Medication Financial Assistance Programs. Journal of the American Heart Association. e014975. PMID 32299284 DOI: 10.1161/Jaha.119.014975 |
0.356 |
|
| 2020 |
Butler J, Anstrom KJ, Armstrong PW. Comparing the Benefit Of Novel Therapies Across Clinical Trials: Insights from the VICTORIA Trial. Circulation. PMID 32223438 DOI: 10.1161/Circulationaha.120.047086 |
0.313 |
|
| 2020 |
Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J, Lam CSP, Ponikowski P, Voors AA, Jia G, McNulty SE, Patel MJ, Roessig L, Koglin J, O'Connor CM, et al. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. The New England Journal of Medicine. PMID 32222134 DOI: 10.1056/Nejmoa1915928 |
0.403 |
|
| 2020 |
Anstrom KJ, Noth I, Flaherty KR, Edwards RH, Albright J, Baucom A, Brooks M, Clark AB, Clausen ES, Durheim MT, Kim DY, Kirchner J, Oldham JM, Snyder LD, Wilson AM, et al. Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial. Respiratory Research. 21: 68. PMID 32164673 DOI: 10.1186/S12931-020-1326-1 |
0.372 |
|
| 2019 |
Butler J, Packer M, Greene SJ, Fiuzat M, Anker SD, Anstrom KJ, Carson PE, Cooper LB, Fonarow GC, Hernandez AF, Januzzi JL, Jessup M, Kalyani RR, Kaul S, Kosiborod M, et al. Heart Failure End Points in Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus: A Critical Evaluation of Clinical and Regulatory Issues. Circulation. 140: 2108-2118. PMID 31841369 DOI: 10.1161/Circulationaha.119.042155 |
0.385 |
|
| 2019 |
Pieske B, Patel MJ, Westerhout CM, Anstrom KJ, Butler J, Ezekowitz J, Hernandez AF, Koglin J, Lam CSP, Ponikowski P, Roessig L, Voors AA, O'Connor CM, Armstrong PW. Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial. European Journal of Heart Failure. PMID 31820546 DOI: 10.1002/Ejhf.1664 |
0.389 |
|
| 2019 |
Fudim M, Kelly JP, Jones AD, AbouEzzeddine OF, Ambrosy AP, Greene SJ, Reddy YNV, Anstrom KJ, Alhanti B, Lewis GD, Hernandez AF, Felker GM. Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure? American Heart Journal. 220: 97-107. PMID 31805424 DOI: 10.1016/J.Ahj.2019.11.006 |
0.396 |
|
| 2019 |
Fanaroff AC, Peterson ED, Kaltenbach LA, Cannon CP, Choudhry NK, Henry TD, Anstrom KJ, Cohen DJ, Fonseca E, Khan ND, Fonarow GC, Wang TY. Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention Medications: A Post Hoc Analysis of the ARTEMIS Cluster-Randomized Clinical Trial. Jama Cardiology. PMID 31721978 DOI: 10.1001/Jamacardio.2019.4408 |
0.339 |
|
| 2019 |
Cunningham JW, Sun JL, Mc Causland FR, Ly S, Anstrom KJ, Lindenfeld J, Givertz MM, Stevenson LW, Lakdawala NK. Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trial. Clinical Cardiology. PMID 31721249 DOI: 10.1002/Clc.23286 |
0.438 |
|
| 2019 |
Januzzi JL, Ahmad T, Mulder H, Coles A, Anstrom KJ, Adams KF, Ezekowitz JA, Fiuzat M, Houston-Miller N, Mark DB, Piña IL, Passmore G, Whellan DJ, Cooper LS, Leifer ES, et al. Natriuretic Peptide Response and Outcomes in Chronic Heart Failure With Reduced Ejection Fraction. Journal of the American College of Cardiology. 74: 1205-1217. PMID 31466618 DOI: 10.1016/J.Jacc.2019.06.055 |
0.426 |
|
| 2019 |
van Diepen S, Mehta RH, Leimberger JD, Goodman SG, Fremes S, Jankowich R, Heringlake M, Anstrom KJ, Levy JH, Luber J, Nagpal AD, Duncan AE, Argenziano M, Toller W, Teoh K, et al. Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery. The Journal of Thoracic and Cardiovascular Surgery. PMID 31358329 DOI: 10.1016/J.Jtcvs.2019.06.020 |
0.356 |
|
| 2019 |
Warraich HJ, O'Connor CM, Yang H, Granger BB, Johnson KS, Mark DB, Anstrom KJ, Patel CB, Steinhauser KE, Tulsky JA, Taylor DH, Rogers JG, Mentz RJ. African Americans with Advanced Heart Failure are More Likely to Die in a Healthcare Facility than Home or Hospice: An Analysis from the PAL-HF Trial. Journal of Cardiac Failure. PMID 31158470 DOI: 10.1016/J.Cardfail.2019.05.013 |
0.361 |
|
| 2019 |
Steinberg BA, Dorian P, Anstrom KJ, Hess R, Mark DB, Noseworthy PA, Spertus JA, Piccini JP. Patient-Reported Outcomes in Atrial Fibrillation Research: Results of a Clinicaltrials.gov Analysis. Jacc. Clinical Electrophysiology. 5: 599-605. PMID 31122382 DOI: 10.1016/J.Jacep.2019.03.008 |
0.336 |
|
| 2019 |
Butler J, Lam CSP, Anstrom KJ, Ezekowitz J, Hernandez AF, O'Connor CM, Pieske B, Ponikowski P, Shah SJ, Solomon SD, Voors AA, Wu Y, Carvalho F, Bamber L, Blaustein RO, et al. Rationale and Design of the VITALITY-HFpEF Trial. Circulation. Heart Failure. 12: e005998. PMID 31096775 DOI: 10.1161/Circheartfailure.119.005998 |
0.384 |
|
| 2019 |
O'Connor C, Fiuzat M, Mulder H, Coles A, Ahmad T, Ezekowitz JA, Adams KF, Piña IL, Anstrom KJ, Cooper LS, Mark DB, Whellan DJ, Januzzi JL, Leifer ES, Felker GM. Clinical factors related to morbidity and mortality in high-risk heart failure patients: the GUIDE-IT predictive model and risk score. European Journal of Heart Failure. PMID 30919549 DOI: 10.1002/Ejhf.1450 |
0.395 |
|
| 2019 |
Mark DB, Anstrom KJ, Sheng S, Piccini JP, Baloch KN, Monahan KH, Daniels MR, Bahnson TD, Poole JE, Rosenberg Y, Lee KL, Packer DL. Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial. Jama. PMID 30874716 DOI: 10.1001/Jama.2019.0692 |
0.32 |
|
| 2019 |
Wang TY, Kaltenbach LA, Cannon CP, Fonarow GC, Choudhry NK, Henry TD, Cohen DJ, Bhandary D, Khan ND, Anstrom KJ, Peterson ED. Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial. Jama. 321: 44-55. PMID 30620370 DOI: 10.1001/Jama.2018.19791 |
0.383 |
|
| 2019 |
Daubert MA, Adams K, Yow E, Barnhart HX, Douglas PS, Rimmer S, Norris C, Cooper L, Leifer E, Desvigne-Nickens P, Anstrom K, Fiuzat M, Ezekowitz J, Mark DB, O'Connor CM, et al. NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF. Jacc. Heart Failure. PMID 30611722 DOI: 10.1016/J.Jchf.2018.10.014 |
0.393 |
|
| 2019 |
Cunningham J, Sun J, Anstrom K, Lindenfeld J, Givertz M, Stevenson L, Lakdawala N. LOW URINE SODIUM PREDICTS LENGTH OF STAY BUT NOT RESPONSE TO DOPAMINE OR NESIRITIDE IN HOSPITALIZED PATIENTS WITH ACUTE HEART FAILURE AND RENAL DYSFUNCTION Journal of the American College of Cardiology. 73: 777. DOI: 10.1016/S0735-1097(19)31385-3 |
0.383 |
|
| 2019 |
Pokorney S, House J, Granger CB, Hylek E, Alberts M, Anstrom K, Berger P, Dorsch M, Naccarelli G, Thomas K, Zambon R, Fermann G. LOW RATES OF ORAL ANTICOAGULATION USE AND POOR OUTCOMES AMONG FRAIL PATIENTS HOSPITALIZED WITH ATRIAL FIBRILLATION Journal of the American College of Cardiology. 73: 323. DOI: 10.1016/S0735-1097(19)30931-3 |
0.329 |
|
| 2019 |
Wan L, O'Connor C, Stebbins A, Alhanti B, Samsky MD, Warraich HJ, Johnson KS, Anstrom KJ, Fiuzat M, Granger BB, Mark DB, Tulsky JA, Rogers JG, Mentz RJ. Patterns of Change in Quality of Life with a Palliative Care Intervention for Patients with Advanced Heart Failure: Insights from PAL-HF Journal of Cardiac Failure. 25. DOI: 10.1016/J.Cardfail.2019.07.444 |
0.345 |
|
| 2019 |
Fiuzat M, Alemayehu W, Ezekowitz J, Westerhout C, Whellan D, Mulder H, Ahmad T, Adams K, Pina I, Anstrom K, Cooper L, Alhanti B, Sbolli M, Mark D, Leifer E, et al. Optimal Medical Therapy in Heart Failure: Reasons for Lack of Medication Titration in the GUIDE IT Trial Journal of Cardiac Failure. 25. DOI: 10.1016/J.Cardfail.2019.07.221 |
0.383 |
|
| 2019 |
Felker GM, Redfield MM, Mentz RJ, Dunlap ME, Lewis GD, Smith AL, McNulty SE, Desvigne-Nickents P, Anstrom KJ, Hernandez AF, Bruanwald E. Subcutaneous Furosemide in the Treatment of Patients with Decompensated Heart Failure: Data from the Sub-Q Pilot Studies Journal of Cardiac Failure. 25: S75. DOI: 10.1016/J.Cardfail.2019.07.213 |
0.372 |
|
| 2018 |
Fudim M, Ambrosy AP, Sun JL, Anstrom KJ, Bart BA, Butler J, AbouEzzeddine O, Greene SJ, Mentz RJ, Redfield MM, Reddy YNV, Vaduganathan M, Braunwald E, Hernandez AF, Borlaug BA, et al. High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network. Journal of the American Heart Association. 7: e010364. PMID 30561266 DOI: 10.1161/Jaha.118.010364 |
0.431 |
|
| 2018 |
Mark DB, Cowper PA, Anstrom KJ, Sheng S, Daniels MR, Knight JD, Baloch KN, Davidson-Ray L, Fiuzat M, Januzzi JL, Whellan DJ, Piña IL, Ezekowitz JA, Adams KF, Cooper LS, et al. Economic and Quality-of-Life Outcomes of Natriuretic Peptide-Guided Therapy for Heart Failure. Journal of the American College of Cardiology. 72: 2551-2562. PMID 30466512 DOI: 10.1016/J.Jacc.2018.08.2184 |
0.404 |
|
| 2018 |
Borlaug BA, Anstrom KJ, Lewis GD, Shah SJ, Levine JA, Koepp GA, Givertz MM, Felker GM, LeWinter MM, Mann DL, Margulies KB, Smith AL, Tang WHW, Whellan DJ, Chen HH, et al. Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial. Jama. 320: 1764-1773. PMID 30398602 DOI: 10.1001/Jama.2018.14852 |
0.382 |
|
| 2018 |
Mentz RJ, O'Connor CM, Granger BB, Yang H, Patel CB, Steinhauser KE, Fiuzat M, Johnson KS, Anstrom KJ, Dodson GC, Taylor DH, Mark DB, Tulsky JA, Rogers JG. Palliative care and hospital readmissions in patients with advanced heart failure: Insights from the PAL-HF trial. American Heart Journal. PMID 30100051 DOI: 10.1016/J.Ahj.2018.07.010 |
0.395 |
|
| 2018 |
Piccini JP, Pokorney SD, Anstrom KJ, Oldenburg O, Punjabi NM, Fiuzat M, Tasissa G, Whellan DJ, Lindenfeld J, Benjafield A, Woehrle H, Blase A, O'Connor CM. Adaptive Servo-Ventilation reduces Atrial Fibrillation Burden in Patients with Heart Failure and Sleep Apnea. Heart Rhythm. PMID 30059750 DOI: 10.1016/J.Hrthm.2018.07.027 |
0.3 |
|
| 2018 |
Daubert MA, Whellan DJ, Woehrle H, Tasissa G, Anstrom KJ, Lindenfeld J, Benjafield A, Blase A, Punjabi N, Fiuzat M, Oldenburg O, O'Connor CM. Treatment of sleep-disordered breathing in heart failure impacts cardiac remodeling: Insights from the CAT-HF Trial. American Heart Journal. 201: 40-48. PMID 29910054 DOI: 10.1016/J.Ahj.2018.03.026 |
0.32 |
|
| 2018 |
Rymer JA, Kaltenbach LA, Anstrom KJ, Fonarow GC, Erskine N, Peterson ED, Wang TY. Hospital evaluation of health literacy and associated outcomes in patients after acute myocardial infarction. American Heart Journal. 198: 97-107. PMID 29653654 DOI: 10.1016/J.Ahj.2017.08.024 |
0.327 |
|
| 2018 |
Abernethy A, Raza S, Sun JL, Anstrom KJ, Tracy R, Steiner J, VanBuren P, LeWinter MM. Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association. 7. PMID 29650706 DOI: 10.1161/Jaha.117.007385 |
0.367 |
|
| 2018 |
Kiernan MS, Stevens SR, Tang WHW, Butler J, Anstrom KJ, Birati EY, Grodin JL, Gupta D, Margulies KB, LaRue S, Dávila-Román VG, Hernandez AF, de Las Fuentes L. Determinants of Diuretic Responsiveness and Associated Outcomes during Acute Heart Failure Hospitalization: an Analysis From the NHLBI Heart Failure Network Clinical Trials. Journal of Cardiac Failure. PMID 29482026 DOI: 10.1016/J.Cardfail.2018.02.002 |
0.401 |
|
| 2018 |
Groarke JD, Stevens SR, Mentz RJ, Cooper LB, Vader JM, AbouEzzeddine OF, Grodin JL, Joyce E, Anstrom KJ, Felker GM, Redfield MM, Stevenson LW, Lala A. Clinical Significance of Early Fluid and Weight Change During Acute Heart Failure Hospitalization. Journal of Cardiac Failure. PMID 29337281 DOI: 10.1016/J.Cardfail.2017.12.013 |
0.365 |
|
| 2018 |
O’Connor CM, Fiuzat M, Coles A, Mulder H, Anstrom K, Ahmad T, Adams K, Pina IL, Cooper L, Nickens P, Mark D, Ezekowitz J, Januzzi J, Leifer E, Felker GM. Co-Morbidities And Ethnicity/Race Predict Morbidity And Mortality In High Risk Heart Failure Patients With Systolic Dysfunction: The Guide-It Predictive Risk Model Journal of the American College of Cardiology. 71. DOI: 10.1016/S0735-1097(18)31381-0 |
0.385 |
|
| 2017 |
Armstrong PW, Roessig L, Patel MJ, Anstrom KJ, Butler J, Voors AA, Lam CSP, Ponikowski P, Temple T, Pieske B, Ezekowitz J, Hernandez AF, Koglin J, O'Connor CM. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator: The VICTORIA Trial. Jacc. Heart Failure. PMID 29032136 DOI: 10.1016/J.Jchf.2017.08.013 |
0.409 |
|
| 2017 |
Felker GM, Anstrom KJ, Adams KF, Ezekowitz JA, Fiuzat M, Houston-Miller N, Januzzi JL, Mark DB, Piña IL, Passmore G, Whellan DJ, Yang H, Cooper LS, Leifer ES, Desvigne-Nickens P, et al. Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. Jama. 318: 713-720. PMID 28829876 DOI: 10.1001/Jama.2017.10565 |
0.438 |
|
| 2017 |
Rogers JG, Patel CB, Mentz RJ, Granger BB, Steinhauser KE, Fiuzat M, Adams PA, Speck A, Johnson KS, Krishnamoorthy A, Yang H, Anstrom KJ, Dodson GC, Taylor DH, Kirchner JL, et al. Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial. Journal of the American College of Cardiology. 70: 331-341. PMID 28705314 DOI: 10.1016/J.Jacc.2017.05.030 |
0.401 |
|
| 2017 |
Butler J, Anstrom KJ, Felker GM, Givertz MM, Kalogeropoulos AP, Konstam MA, Mann DL, Margulies KB, McNulty SE, Mentz RJ, Redfield MM, Tang WHW, Whellan DJ, Shah M, Desvigne-Nickens P, et al. Efficacy and Safety of Spironolactone in Acute Heart Failure: The ATHENA-HF Randomized Clinical Trial. Jama Cardiology. PMID 28700781 DOI: 10.1001/Jamacardio.2017.2198 |
0.395 |
|
| 2017 |
Snipelisky D, Kelly J, Levine JA, Koepp GA, Anstrom KJ, McNulty SE, Zakeri R, Felker GM, Hernandez AF, Braunwald E, Redfield MM. Accelerometer-Measured Daily Activity in Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Association With Standard Heart Failure Severity Indices. Circulation. Heart Failure. 10: e003878. PMID 28588021 DOI: 10.1161/Circheartfailure.117.003878 |
0.372 |
|
| 2017 |
Guimarães PO, Krishnamoorthy A, Kaltenbach LA, Anstrom KJ, Effron MB, Mark DB, McCollam PL, Davidson-Ray L, Peterson ED, Wang TY. Accuracy of Medical Claims for Identifying Cardiovascular and Bleeding Events After Myocardial Infarction : A Secondary Analysis of the TRANSLATE-ACS Study. Jama Cardiology. PMID 28538984 DOI: 10.1001/Jamacardio.2017.1460 |
0.326 |
|
| 2017 |
Lewis GD, Malhotra R, Hernandez AF, McNulty SE, Smith A, Felker GM, Tang WHW, LaRue SJ, Redfield MM, Semigran MJ, Givertz MM, Van Buren P, Whellan D, Anstrom KJ, Shah MR, et al. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial. Jama. 317: 1958-1966. PMID 28510680 DOI: 10.1001/Jama.2017.5427 |
0.349 |
|
| 2017 |
Wang H, Anstrom K, Ilkayeva O, Muehlbauer MJ, Bain JR, McNulty S, Newgard CB, Kraus WE, Hernandez A, Felker GM, Redfield M, Shah SH. Sildenafil Treatment in Heart Failure With Preserved Ejection Fraction: Targeted Metabolomic Profiling in the RELAX Trial. Jama Cardiology. PMID 28492915 DOI: 10.1001/Jamacardio.2017.1239 |
0.379 |
|
| 2017 |
Ambrosy AP, Bhatt AS, Gallup D, Anstrom KJ, Butler J, DeVore AD, Felker GM, Fudim M, Greene SJ, Hernandez AF, Kelly JP, Samsky MD, Mentz RJ. Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network). The American Journal of Cardiology. PMID 28479167 DOI: 10.1016/J.Amjcard.2017.03.249 |
0.44 |
|
| 2017 |
Reddy YNV, Lewis GD, Shah SJ, LeWinter M, Semigran M, Davila-Roman VG, Anstrom K, Hernandez A, Braunwald E, Redfield MM, Borlaug BA. INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design. Circulation. Heart Failure. 10. PMID 28476756 DOI: 10.1161/Circheartfailure.117.003862 |
0.366 |
|
| 2017 |
Fanaroff AC, James SK, Weisz G, Prather K, Anstrom KJ, Mark DB, Ben-Yehuda O, Alexander KP, Stone GW, Ohman EM. Ranolazine After Incomplete Percutaneous Coronary Revascularization in Patients With Versus Without Diabetes Mellitus: RIVER-PCI Trial. Journal of the American College of Cardiology. 69: 2304-2313. PMID 28473136 DOI: 10.1016/J.Jacc.2017.02.056 |
0.301 |
|
| 2017 |
Bagai A, Peterson ED, McCoy LA, Effron MB, Zettler ME, Stone GW, Henry TD, Cohen DJ, Schulte PJ, Anstrom KJ, Wang TY. Association of measured platelet reactivity with changes in P2Y12 receptor inhibitor therapy and outcomes after myocardial infarction: Insights into routine clinical practice from the TReatment with ADP receptor iNhibitorS: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study. American Heart Journal. 187: 19-28. PMID 28454802 DOI: 10.1016/J.Ahj.2017.02.003 |
0.556 |
|
| 2017 |
Grodin JL, Gallup D, Anstrom KJ, Felker GM, Chen HH, Tang WHW. Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF). The American Journal of Cardiology. PMID 28433216 DOI: 10.1016/J.Amjcard.2017.03.031 |
0.376 |
|
| 2017 |
Cowper PA, Sheng S, Lopes RD, Anstrom KJ, Stafford JA, Davidson-Ray L, Al-Khatib SM, Ansell J, Dorian P, Husted S, McMurray JJ, Steg PG, Alexander JH, Wallentin L, Granger CB, et al. Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial. Jama Cardiology. PMID 28355434 DOI: 10.1001/Jamacardio.2017.0065 |
0.333 |
|
| 2017 |
O'Connor CM, Whellan DJ, Fiuzat M, Punjabi NM, Tasissa G, Anstrom KJ, Benjafield AV, Woehrle H, Blase AB, Lindenfeld J, Oldenberg O. Cardiovascular Outcomes With Minute Ventilation-Targeted Adaptive Servo-Ventilation Therapy in Heart Failure: The CAT-HF Trial. Journal of the American College of Cardiology. 69: 1577-1587. PMID 28335841 DOI: 10.1016/J.Jacc.2017.01.041 |
0.396 |
|
| 2017 |
Mehta RH, Leimberger JD, van Diepen S, Meza J, Wang A, Jankowich R, Harrison RW, Hay D, Fremes S, Duncan A, Soltesz EG, Luber J, Park S, Argenziano M, Murphy E, ... ... Anstrom KJ, et al. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery. The New England Journal of Medicine. PMID 28316276 DOI: 10.1056/Nejmoa1616218 |
0.37 |
|
| 2017 |
DeVore AD, McNulty S, Alenezi F, Ersboll M, Vader JM, Oh JK, Lin G, Redfield MM, Lewis G, Semigran MJ, Anstrom KJ, Hernandez AF, Velazquez EJ. Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial. European Journal of Heart Failure. PMID 28194841 DOI: 10.1002/Ejhf.754 |
0.37 |
|
| 2017 |
Eisenstein EL, Willis JM, Edwards R, Anstrom KJ, Kawamoto K, Fiol GD, Johnson FS, Lobach DF. Randomized Trial of Population-Based Clinical Decision Support to Facilitate Care Transitions. Studies in Health Technology and Informatics. 234: 98-103. PMID 28186023 DOI: 10.3233/978-1-61499-742-9-98 |
0.347 |
|
| 2017 |
Zettler ME, Peterson ED, McCoy LA, Effron MB, Anstrom KJ, Henry TD, Baker BA, Messenger JC, Cohen DJ, Wang TY. Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational study. American Heart Journal. 183: 62-68. PMID 27979043 DOI: 10.1016/J.Ahj.2016.10.006 |
0.353 |
|
| 2017 |
Benjafield A, Lindenfeld J, Oldenburg O, Whellan D, Fiuzat M, Punjabi N, Anstrom K, Blase A, Woehrle H. SURROGATE ENDPOINTS AND THE DIFFERENTIAL RESPONSE TO ASV FOR SLEEP APNEA IN HFREF VERSUS HFPEF IN THE CAT-HF TRIAL Journal of the American College of Cardiology. 69: 708. DOI: 10.1016/S0735-1097(17)34097-4 |
0.353 |
|
| 2017 |
Pokorney S, Granger C, Anstrom K, Kline-Rogers E, Alberts M, Naccarelli G, Berger P, House JA, Vijapurkar U, Davidson J, Shah B, Hylek E. RATES OF ORAL ANTICOAGULANT USE, WHILE IMPROVING OVER TIME, REMAIN LOW AMONG HOSPITALIZED PATIENTS WITH ATRIAL FIBRILLATION Journal of the American College of Cardiology. 69: 363. DOI: 10.1016/S0735-1097(17)33752-X |
0.311 |
|
| 2017 |
Felker GM, Anstrom KJ, Adams KF, Ezekowitz JA, Fiuzat M, Houston-Miller N, Januzzi JL, Mark DB, Piña IL, Passmore G, Whellan DJ, Yang H, Cooper LS, Leifer ES, Desvigne-Nickens P, et al. Effect of Natriuretic Peptide-Guided Therapy on Outcomes in High-Risk Patients with Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial Journal of Cardiac Failure. 23: 830. DOI: 10.1016/J.Cardfail.2017.10.004 |
0.41 |
|
| 2016 |
Mehta RH, Van Diepen S, Meza J, Bokesch P, Leimberger JD, Tourt-Uhlig S, Swartz M, Parrotta J, Jankowich R, Hay D, Harrison RW, Fremes S, Goodman SG, Luber J, Toller W, ... ... Anstrom KJ, et al. Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial. American Heart Journal. 182: 62-71. PMID 27914501 DOI: 10.1016/J.Ahj.2016.09.001 |
0.323 |
|
| 2016 |
Joyce E, Lala A, Stevens SR, Cooper LB, AbouEzzeddine OF, Groarke JD, Grodin JL, Braunwald E, Anstrom KJ, Redfield MM, Stevenson LW. Prevalence, Profile, and Prognosis of Severe Obesity in Contemporary Hospitalized Heart Failure Trial Populations. Jacc. Heart Failure. 4: 923-931. PMID 27908391 DOI: 10.1016/J.Jchf.2016.09.013 |
0.335 |
|
| 2016 |
Grodin JL, Sun JL, Anstrom KJ, Chen HH, Starling RC, Testani JM, Tang WH. Implications of Serum Chloride Homeostasis in Acute Heart Failure (from ROSE-AHF). The American Journal of Cardiology. PMID 27816115 DOI: 10.1016/J.Amjcard.2016.09.014 |
0.363 |
|
| 2016 |
Fosbøl EL, Ju C, Anstrom KJ, Zettler ME, Messenger JC, Waksman R, Effron MB, Baker BA, Cohen DJ, Peterson ED, Wang TY. Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome). Circulation. Cardiovascular Interventions. 9. PMID 27789517 DOI: 10.1161/Circinterventions.115.003602 |
0.345 |
|
| 2016 |
Cooper LB, Mi X, Mentz RJ, Green JB, Anstrom KJ, Hernandez AF, Curtis LH. Management of newly treated diabetes in Medicare beneficiaries with and without heart failure. Clinical Cardiology. PMID 27783884 DOI: 10.1002/Clc.22603 |
0.327 |
|
| 2016 |
Gandhi PU, Gaggin HK, Redfield MM, Chen HH, Stevens SR, Anstrom KJ, Semigran MJ, Liu P, Januzzi JL. Insulin-Like Growth Factor-Binding Protein 7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial. Jacc. Heart Failure. PMID 27744089 DOI: 10.1016/J.Jchf.2016.08.002 |
0.321 |
|
| 2016 |
Vora AN, Peterson ED, McCoy LA, Effron MB, Anstrom KJ, Faries DE, Zettler ME, Fonarow GC, Baker BA, Stone GW, Wang TY. Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) Study. Journal of the American Heart Association. 5. PMID 27663414 DOI: 10.1161/Jaha.116.003946 |
0.382 |
|
| 2016 |
Butler J, Hernandez AF, Anstrom KJ, Kalogeropoulos A, Redfield MM, Konstam MA, Tang WH, Felker GM, Shah MR, Braunwald E. Rationale and Design of the ATHENA-HF Trial: Aldosterone Targeted Neurohormonal Combined With Natriuresis Therapy in Heart Failure. Jacc. Heart Failure. PMID 27522631 DOI: 10.1016/J.Jchf.2016.06.003 |
0.427 |
|
| 2016 |
Kelly JP, Cooper LB, Gallup D, Anstrom KJ, Chen HH, Redfield MM, O'Connor CM, Mentz RJ, Hernanadez AF, Felker GM. Implications of Using Different Definitions on Outcomes in Worsening Heart Failure. Circulation. Heart Failure. 9. PMID 27514750 DOI: 10.1161/Circheartfailure.116.003048 |
0.397 |
|
| 2016 |
Wan SH, Stevens SR, Borlaug BA, Anstrom KJ, Deswal A, Felker GM, Givertz MM, Bart BA, Tang WH, Redfield MM, Chen HH. Differential Response to Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Reduced or Preserved Ejection Fraction: Results From the ROSE AHF Trial (Renal Optimization Strategies Evaluation in Acute Heart Failure). Circulation. Heart Failure. 9. PMID 27512103 DOI: 10.1161/Circheartfailure.115.002593 |
0.356 |
|
| 2016 |
Kaul P, Ohman EM, Knight JD, Anstrom KJ, Roe MT, Boden WE, Hochman JS, Gašparović V, Armstrong PW, McCollam P, Fakhouri W, Cowper P, Davidson-Ray L, Clapp-Channing N, White HD, et al. Health-related quality of life outcomes with prasugrel among medically managed non-ST-segment elevation acute coronary syndrome patients: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes (TRILOGY ACS) trial. American Heart Journal. 178: 55-64. PMID 27502852 DOI: 10.1016/J.Ahj.2016.03.017 |
0.382 |
|
| 2016 |
Brown PM, Anstrom KJ, Felker GM, Ezekowitz JA. Composite End Points in Acute Heart Failure Research: Data Simulations Illustrate the Limitations. The Canadian Journal of Cardiology. PMID 27499377 DOI: 10.1016/J.Cjca.2016.02.067 |
0.324 |
|
| 2016 |
Margulies KB, Hernandez AF, Redfield MM, Givertz MM, Oliveira GH, Cole R, Mann DL, Whellan DJ, Kiernan MS, Felker GM, McNulty SE, Anstrom KJ, Shah MR, Braunwald E, Cappola TP, et al. Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial. Jama. 316: 500-508. PMID 27483064 DOI: 10.1001/Jama.2016.10260 |
0.397 |
|
| 2016 |
Federspiel JJ, Anstrom KJ, Xian Y, McCoy LA, Effron MB, Faries DE, Zettler M, Mauri L, Yeh RW, Peterson ED, Wang TY. Comparing Inverse Probability of Treatment Weighting and Instrumental Variable Methods for the Evaluation of Adenosine Diphosphate Receptor Inhibitors After Percutaneous Coronary Intervention. Jama Cardiology. PMID 27438179 DOI: 10.1001/Jamacardio.2016.1783 |
0.303 |
|
| 2016 |
Zeitler EP, Wang Y, Dharmarajan K, Anstrom KJ, Peterson ED, Daubert JP, Curtis JP, Al-Khatib SM. Outcomes 1 Year After Implantable Cardioverter-Defibrillator Lead Abandonment Versus Explantation for Unused or Malfunctioning Leads: A Report from the National Cardiovascular Data Registry. Circulation. Arrhythmia and Electrophysiology. 9. PMID 27406605 DOI: 10.1161/Circep.116.003953 |
0.32 |
|
| 2016 |
Doll JA, Wang TY, Choudhry NK, Cannon CP, Cohen DJ, Fonarow GC, Henry TD, Bhandary DD, Khan N, Davidson-Ray LD, Anstrom K, Peterson ED. Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction. American Heart Journal. 177: 33-41. PMID 27297847 DOI: 10.1016/J.Ahj.2016.04.008 |
0.352 |
|
| 2016 |
Mark DB, Anstrom KJ, Sheng S, Baloch KN, Daniels MR, Hoffmann U, Patel MR, Cooper LS, Lee KL, Douglas PS. Quality of Life Outcomes With Anatomic Versus Functional Diagnostic Testing Strategies in Symptomatic Patients With Suspected Coronary Artery Disease: Results From the PROMISE Randomized Trial. Circulation. PMID 27143676 DOI: 10.1161/Circulationaha.115.020259 |
0.346 |
|
| 2016 |
Lewis GD, Semigran MJ, Givertz MM, Malhotra R, Anstrom KJ, Hernandez AF, Shah MR, Braunwald E. Oral Iron Therapy for Heart Failure With Reduced Ejection Fraction: Design and Rationale for Oral Iron Repletion Effects on Oxygen Uptake in Heart Failure. Circulation. Heart Failure. 9. PMID 27140203 DOI: 10.1161/Circheartfailure.115.000345 |
0.333 |
|
| 2016 |
AbouEzzeddine OF, Lala A, Khazanie PP, Shah R, Ho JE, Chen HH, Pang PS, McNulty SE, Anstrom KJ, Hernandez AF, Redfield MM. Evaluation of a provocative dyspnea severity score in acute heart failure. American Heart Journal. 172: 34-41. PMID 26856213 DOI: 10.1016/J.Ahj.2015.10.009 |
0.348 |
|
| 2016 |
O'Brien EC, Durheim MT, Gamerman V, Garfinkel S, Anstrom KJ, Palmer SM, Conoscenti CS. Rationale for and design of the Idiopathic Pulmonary Fibrosis-PRospective Outcomes (IPF-PRO) registry. Bmj Open Respiratory Research. 3: e000108. PMID 26835134 DOI: 10.1136/Bmjresp-2015-000108 |
0.361 |
|
| 2016 |
Krishnamoorthy A, Peterson ED, Knight JD, Anstrom KJ, Effron MB, Zettler ME, Davidson-Ray L, Baker BA, McCollam PL, Mark DB, Wang TY. How Reliable are Patient-Reported Rehospitalizations? Implications for the Design of Future Practical Clinical Studies. Journal of the American Heart Association. 5. PMID 26811163 DOI: 10.1161/Jaha.115.002695 |
0.391 |
|
| 2016 |
Fiuzat M, Oldenberg O, Whellan DJ, Woehrle H, Punjabi NM, Anstrom KJ, Blase AB, Benjafield AV, Lindenfeld J, O'Connor CM. Lessons learned from a clinical trial: Design, rationale, and insights from The Cardiovascular Improvements with Minute Ventilation-targeted Adaptive Sero-Ventilation (ASV) Therapy in Heart Failure (CAT-HF) Study. Contemporary Clinical Trials. 47: 158-164. PMID 26806668 DOI: 10.1016/J.Cct.2016.01.001 |
0.376 |
|
| 2016 |
Cooper LB, Mentz RJ, Gallup D, Lala A, DeVore AD, Vader JM, AbouEzzeddine OF, Bart BA, Anstrom KJ, Hernandez AF, Felker GM. Serum Bicarbonate in Acute Heart Failure: Relationship to Treatment Strategies and Clinical Outcomes. Journal of Cardiac Failure. PMID 26777758 DOI: 10.1016/J.Cardfail.2016.01.007 |
0.409 |
|
| 2016 |
Rogers J, Patel C, Mentz R, Steinhauser K, Granger B, Fiuzat M, Adams P, Speck A, Johnson K, Krishnamoorthy A, Yang H, Anstrom K, Dodson G, O'Connor C, Tulsky J. Palliative Care in Heart Failure: Results of a Randomized, Controlled Clinical Trial Journal of Cardiac Failure. 22: 940. DOI: 10.1016/J.Cardfail.2016.09.014 |
0.36 |
|
| 2015 |
AbouEzzeddine OF, Wong YW, Mentz RJ, Raza SS, Nativi-Nicolau J, Kociol RD, McNulty SE, Anstrom KJ, Hernandez AF, Redfield MM. Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: the Worst Symptom Score. Journal of Cardiac Failure. PMID 26718344 DOI: 10.1016/J.Cardfail.2015.12.015 |
0.341 |
|
| 2015 |
Mentz RJ, Hasselblad V, DeVore AD, Metra M, Voors AA, Armstrong PW, Ezekowitz JA, Tang WH, Schulte PJ, Anstrom KJ, Hernandez AF, Velazquez EJ, O'Connor CM. Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial). The American Journal of Cardiology. PMID 26704029 DOI: 10.1016/J.Amjcard.2015.10.059 |
0.63 |
|
| 2015 |
Alexander KP, Weisz G, Prather K, James S, Mark DB, Anstrom KJ, Davidson-Ray L, Witkowski A, Mulkay AJ, Osmukhina A, Farzaneh-Far R, Ben-Yehuda O, Stone GW, Ohman EM. Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial. Circulation. PMID 26555329 DOI: 10.1161/Circulationaha.115.019768 |
0.313 |
|
| 2015 |
Redfield MM, Anstrom KJ, Levine JA, Koepp GA, Borlaug BA, Chen HH, LeWinter MM, Joseph SM, Shah SJ, Semigran MJ, Felker GM, Cole RT, Reeves GR, Tedford RJ, Tang WH, et al. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction. The New England Journal of Medicine. PMID 26549714 DOI: 10.1056/Nejmoa1510774 |
0.345 |
|
| 2015 |
Khazanie P, Hellkamp AS, Fonarow GC, Bhatt DL, Masoudi FA, Anstrom KJ, Heidenreich PA, Yancy CW, Curtis LH, Hernandez AF, Peterson ED, Al-Khatib SM. Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention. Journal of the American Heart Association. 4: e002061. PMID 26251283 DOI: 10.1161/Jaha.115.002061 |
0.433 |
|
| 2015 |
Grodin JL, Stevens SR, Lisa LF, Kiernan M, Birati EY, Gupta D, Bart BA, Felker GM, Chen HH, Butler J, Dávila-Román VG, Margulies KB, Hernandez AF, Anstrom KJ, Tang WH. Intensification of Medication Therapy for Cardiorenal Syndrome in Acute Decompensated Heart Failure. Journal of Cardiac Failure. PMID 26209004 DOI: 10.1016/J.Cardfail.2015.07.007 |
0.37 |
|
| 2015 |
Lala A, McNulty SE, Mentz RJ, Dunlay SM, Vader JM, AbouEzzeddine OF, DeVore AD, Khazanie P, Redfield MM, Goldsmith SR, Bart BA, Anstrom KJ, Felker GM, Hernandez AF, Stevenson LW. Relief and Recurrence of Congestion During and After Hospitalization for Acute Heart Failure: Insights From Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Circulation. Heart Failure. 8: 741-8. PMID 26041600 DOI: 10.1161/Circheartfailure.114.001957 |
0.39 |
|
| 2015 |
Wang TY, Henry TD, Effron MB, Honeycutt E, Hess CN, Zettler ME, Cohen DJ, Baker BA, Berger PB, Anstrom KJ, Angiolillo DJ, Peterson ED. Cluster-randomized clinical trial examining the impact of platelet function testing on practice: the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy study. Circulation. Cardiovascular Interventions. 8: e001712. PMID 26025216 DOI: 10.1161/Circinterventions.114.001712 |
0.324 |
|
| 2015 |
Givertz MM, Anstrom KJ, Redfield MM, Deswal A, Haddad H, Butler J, Tang WH, Dunlap ME, LeWinter MM, Mann DL, Felker GM, O'Connor CM, Goldsmith SR, Ofili EO, Saltzberg MT, et al. Effects of Xanthine Oxidase Inhibition in Hyperuricemic Heart Failure Patients: The Xanthine Oxidase Inhibition for Hyperuricemic Heart Failure Patients (EXACT-HF) Study. Circulation. 131: 1763-71. PMID 25986447 DOI: 10.1161/Circulationaha.114.014536 |
0.377 |
|
| 2015 |
Mentz RJ, Buggey J, Fiuzat M, Ersbøll MK, Schulte PJ, DeVore AD, Eisenstein EL, Anstrom KJ, OʼConnor CM, Velazquez EJ. Torsemide versus furosemide in heart failure patients: insights from Duke University Hospital. Journal of Cardiovascular Pharmacology. 65: 438-43. PMID 25945862 DOI: 10.1097/Fjc.0000000000000212 |
0.623 |
|
| 2015 |
Durheim MT, Collard HR, Roberts RS, Brown KK, Flaherty KR, King TE, Palmer SM, Raghu G, Snyder LD, Anstrom KJ, Martinez FJ. Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials. The Lancet. Respiratory Medicine. 3: 388-96. PMID 25890798 DOI: 10.1016/S2213-2600(15)00093-4 |
0.355 |
|
| 2015 |
Steinberg BA, Schulte PJ, Hofmann P, Ersbøll M, Alexander JH, Broderick-Forsgren K, Anstrom KJ, Granger CB, Piccini JP, Velazquez EJ, Shah BR. Outcomes after nonemergent electrical cardioversion for atrial arrhythmias. The American Journal of Cardiology. 115: 1407-14. PMID 25784514 DOI: 10.1016/J.Amjcard.2015.02.030 |
0.591 |
|
| 2015 |
Buggey J, Mentz RJ, Pitt B, Eisenstein EL, Anstrom KJ, Velazquez EJ, O'Connor CM. A reappraisal of loop diuretic choice in heart failure patients. American Heart Journal. 169: 323-33. PMID 25728721 DOI: 10.1016/J.Ahj.2014.12.009 |
0.405 |
|
| 2015 |
Brennan JM, Al-Hejily W, Dai D, Shaw RE, Trilesskaya M, Rao SV, Brilakis ES, Anstrom KJ, Messenger JC, Peterson ED, Douglas PS, Sketch MH. Three-year outcomes associated with embolic protection in saphenous vein graft intervention: results in 49 325 senior patients in the Medicare-linked National Cardiovascular Data Registry CathPCI Registry. Circulation. Cardiovascular Interventions. 8: e001403. PMID 25714391 DOI: 10.1161/Circinterventions.114.001403 |
0.307 |
|
| 2015 |
Cowper PA, Pan W, Anstrom KJ, Kaul P, Wallentin L, Davidson-Ray L, Nikolic E, Janzon M, Levin LÅ, Cannon CP, Harrington RA, Mark DB. Economic analysis of ticagrelor therapy from a U.S. perspective: results from the PLATO study. Journal of the American College of Cardiology. 65: 465-76. PMID 25660925 DOI: 10.1016/J.Jacc.2014.11.034 |
0.363 |
|
| 2015 |
Povsic TJ, Broderick S, Anstrom KJ, Shaw LK, Ohman EM, Eisenstein EL, Smith PK, Alexander JH. Predictors of long-term clinical endpoints in patients with refractory angina. Journal of the American Heart Association. 4. PMID 25637344 DOI: 10.1161/Jaha.114.001287 |
0.448 |
|
| 2015 |
Zakeri R, Levine JA, Koepp GA, Borlaug BA, Chirinos JA, LeWinter M, VanBuren P, Dávila-Román VG, de Las Fuentes L, Khazanie P, Hernandez A, Anstrom K, Redfield MM. Nitrate's effect on activity tolerance in heart failure with preserved ejection fraction trial: rationale and design. Circulation. Heart Failure. 8: 221-8. PMID 25605640 DOI: 10.1161/Circheartfailure.114.001598 |
0.416 |
|
| 2015 |
Mentz RJ, Stevens SR, DeVore AD, Lala A, Vader JM, AbouEzzeddine OF, Khazanie P, Redfield MM, Stevenson LW, O'Connor CM, Goldsmith SR, Bart BA, Anstrom KJ, Hernandez AF, Braunwald E, et al. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure. Jacc. Heart Failure. 3: 97-107. PMID 25543972 DOI: 10.1016/j.jchf.2014.09.003 |
0.344 |
|
| 2015 |
Pokorney SD, Hellkamp AS, Yancy CW, Curtis LH, Hammill SC, Peterson ED, Masoudi FA, Bhatt DL, Al-Khalidi HR, Heidenreich PA, Anstrom KJ, Fonarow GC, Al-Khatib SM. Primary prevention implantable cardioverter-defibrillators in older racial and ethnic minority patients. Circulation. Arrhythmia and Electrophysiology. 8: 145-51. PMID 25504649 DOI: 10.1161/Circep.114.001878 |
0.317 |
|
| 2015 |
Al-Khatib SM, Daubert JP, Anstrom KJ, Daoud EG, Gonzalez M, Saba S, Jackson KP, Reece T, Gu J, Pokorney SD, Granger CB, Hess PL, Mark DB, Stevenson WG. Catheter ablation for ventricular tachycardia in patients with an implantable cardioverter defibrillator (CALYPSO) pilot trial. Journal of Cardiovascular Electrophysiology. 26: 151-7. PMID 25332150 DOI: 10.1111/Jce.12567 |
0.366 |
|
| 2015 |
De Andrade J, Schwarz M, Collard HR, Gentry-Bumpass T, Colby T, Lynch D, Kaner RJ, Zisman DA, Chapman J, Olman M, Lubell S, Morrison LD, Steele MP, Haram T, Roman J, ... ... Anstrom KJ, et al. The idiopathic pulmonary fibrosis clinical research network (IPFnet): Diagnostic and adjudication processes Chest. 148: 1034-1042. DOI: 10.1378/Chest.14-2889 |
0.347 |
|
| 2015 |
Mentz RJ, Buggey J, Fiuzat M, ErsbØll MK, Schulte PJ, DeVore AD, Eisenstein EL, Anstrom KJ, O'Connor CM, Velazquez EJ. Torsemide versus furosemide in heart failure patients: Insights from duke university hospital Journal of Cardiovascular Pharmacology. 65: 438-443. DOI: 10.1097/FJC.0000000000000212 |
0.548 |
|
| 2015 |
Vora A, Peterson E, McCoy L, Effron M, Anstrom K, Faries D, Zettler M, Fonarow G, Baker B, Stone G, Wang T. SELECTION OF PRASUGREL VERSUS CLOPIDOGREL AMONG MYOCARDIAL INFARCTION PATIENTS WITH HIGH VERSUS LOW PREDICTED MORTALITY AND BLEEDING RISKS: INSIGHTS FROM TRANSLATE-ACS Journal of the American College of Cardiology. 65: A107. DOI: 10.1016/S0735-1097(15)60107-3 |
0.335 |
|
| 2015 |
Bagai A, Peterson E, McCoy L, Effron M, Stone G, Henry T, Cohen D, Schulte P, Anstrom K, Wang T. PLATELET REACTIVITY, P2Y12 RECEPTOR INHIBITOR SELECTION AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION TREATED WITH PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE TRANSLATE-ACS STUDY Canadian Journal of Cardiology. 31: S25. DOI: 10.1016/J.Cjca.2015.07.066 |
0.577 |
|
| 2014 |
Bagai A, Peterson ED, Honeycutt E, Effron MB, Cohen DJ, Goodman SG, Anstrom KJ, Gupta A, Messenger JC, Wang TY. In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study. European Heart Journal. Acute Cardiovascular Care. PMID 25515725 DOI: 10.1177/2048872614564082 |
0.389 |
|
| 2014 |
Mentz RJ, Tulsky JA, Granger BB, Anstrom KJ, Adams PA, Dodson GC, Fiuzat M, Johnson KS, Patel CB, Steinhauser KE, Taylor DH, O'Connor CM, Rogers JG. The palliative care in heart failure trial: rationale and design. American Heart Journal. 168: 645-651.e1. PMID 25440791 DOI: 10.1016/J.Ahj.2014.07.018 |
0.349 |
|
| 2014 |
Mark DB, Knight JD, Velazquez EJ, Wasilewski J, Howlett JG, Smith PK, Spertus JA, Rajda M, Yadav R, Hamman BL, Malinowski M, Naik A, Rankin G, Harding TM, Drew LA, ... ... Anstrom KJ, et al. Quality-of-life outcomes with coronary artery bypass graft surgery in ischemic left ventricular dysfunction: a randomized trial. Annals of Internal Medicine. 161: 392-9. PMID 25222386 DOI: 10.7326/M13-1380 |
0.383 |
|
| 2014 |
Xian Y, Holloway RG, Smith EE, Schwamm LH, Reeves MJ, Bhatt DL, Schulte PJ, Cox M, Olson DM, Hernandez AF, Lytle BL, Anstrom KJ, Fonarow GC, Peterson ED. Racial/Ethnic differences in process of care and outcomes among patients hospitalized with intracerebral hemorrhage. Stroke; a Journal of Cerebral Circulation. 45: 3243-50. PMID 25213344 DOI: 10.1161/Strokeaha.114.005620 |
0.524 |
|
| 2014 |
Felker GM, Ahmad T, Anstrom KJ, Adams KF, Cooper LS, Ezekowitz JA, Fiuzat M, Houston-Miller N, Januzzi JL, Leifer ES, Mark DB, Desvigne-Nickens P, Paynter G, Piña IL, Whellan DJ, et al. Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure. Jacc. Heart Failure. 2: 457-65. PMID 25194287 DOI: 10.1016/J.Jchf.2014.05.007 |
0.379 |
|
| 2014 |
Rao SV, Hess CN, Barham B, Aberle LH, Anstrom KJ, Patel TB, Jorgensen JP, Mazzaferri EL, Jolly SS, Jacobs A, Newby LK, Gibson CM, Kong DF, Mehran R, Waksman R, et al. A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. Jacc. Cardiovascular Interventions. 7: 857-67. PMID 25147030 DOI: 10.1016/J.Jcin.2014.04.007 |
0.304 |
|
| 2014 |
Collard HR, Brown KK, Martinez FJ, Raghu G, Roberts RS, Anstrom KJ. Study design implications of death and hospitalization as end points in idiopathic pulmonary fibrosis. Chest. 146: 1256-62. PMID 25144827 DOI: 10.1378/Chest.14-0492 |
0.332 |
|
| 2014 |
Piccini JP, Al-Khatib SM, Wojdyla DM, Shaw LK, Horton JR, Lokhnygina Y, Anstrom KJ, DeWald T, Allen-LaPointe N, Steinberg BA, Thomas K, Daubert JP, Peterson ED. Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease. The American Journal of Cardiology. 114: 716-22. PMID 25129065 DOI: 10.1016/J.Amjcard.2014.06.004 |
0.613 |
|
| 2014 |
Anstrom KJ, Brennan JM, Eisenstein EL, Federspiel JJ, Dai D, Peterson ED, Douglas PS. Examination of the treatment selection process in a multicenter observational study. Circulation. Cardiovascular Quality and Outcomes. 7: 764-9. PMID 25116898 DOI: 10.1161/Circoutcomes.113.000482 |
0.313 |
|
| 2014 |
Hess CN, Roe MT, Gibson CM, Temple RJ, Pencina MJ, Zarin DA, Anstrom KJ, Alexander JH, Sherman RE, Fiedorek FT, Mahaffey KW, Lee KL, Chow SC, Armstrong PW, Califf RM. Independent data monitoring committees: preparing a path for the future. American Heart Journal. 168: 135-41.e1. PMID 25066551 DOI: 10.1016/J.Ahj.2014.05.003 |
0.314 |
|
| 2014 |
Margulies KB, Anstrom KJ, Hernandez AF, Redfield MM, Shah MR, Braunwald E, Cappola TP. GLP-1 agonist therapy for advanced heart failure with reduced ejection fraction: design and rationale for the functional impact of GLP-1 for heart failure treatment study. Circulation. Heart Failure. 7: 673-9. PMID 25028349 DOI: 10.1161/Circheartfailure.114.000346 |
0.419 |
|
| 2014 |
Mark DB, Anstrom KJ, Clapp-Channing NE, Knight JD, Boineau R, Goertz C, Rozema TC, Liu DM, Nahin RL, Rosenberg Y, Drisko J, Lee KL, Lamas GA. Quality-of-life outcomes with a disodium EDTA chelation regimen for coronary disease: results from the trial to assess chelation therapy randomized trial. Circulation. Cardiovascular Quality and Outcomes. 7: 508-16. PMID 24987051 DOI: 10.1161/Circoutcomes.114.000977 |
0.391 |
|
| 2014 |
Al-Khatib SM, Hellkamp AS, Fonarow GC, Mark DB, Curtis LH, Hernandez AF, Anstrom KJ, Peterson ED, Sanders GD, Al-Khalidi HR, Hammill BG, Heidenreich PA, Hammill SC. Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%. Jama. 311: 2209-15. PMID 24893088 DOI: 10.1001/Jama.2014.5310 |
0.421 |
|
| 2014 |
Douglas PS, Hoffmann U, Lee KL, Mark DB, Al-Khalidi HR, Anstrom K, Dolor RJ, Kosinski A, Krucoff MW, Mudrick DW, Patel MR, Picard MH, Udelson JE, Velazquez EJ, Cooper L, et al. PROspective Multicenter Imaging Study for Evaluation of chest pain: rationale and design of the PROMISE trial. American Heart Journal. 167: 796-803.e1. PMID 24890527 DOI: 10.1016/J.Ahj.2014.03.003 |
0.342 |
|
| 2014 |
Kutcher MA, Brennan JM, Rao SV, Dai D, Anstrom KJ, Mustafa N, Sedrakyan A, Sedrakayan A, Booth ME, Douglas PS, Messenger JC. Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: a report from the National Cardiovascular Data Registry. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 83: 171-81. PMID 23907981 DOI: 10.1002/Ccd.25108 |
0.324 |
|
| 2014 |
Wong YW, Anstrom K, McNulty S, Hernandez A, Felker GM. CIRCULATING SURFACTANT PROTEINS, DYSPNEA, AND MARKERS OF CONGESTION IN ACUTE DECOMPENSATED HEART FAILURE: REPORT FROM THE DIURETIC OPTIMIZATION STRATEGIES EVALUATION (DOSE) STUDY Journal of the American College of Cardiology. 63: A919. DOI: 10.1016/S0735-1097(14)60919-0 |
0.332 |
|
| 2014 |
Mentz RJ, Buggey J, Schulte PJ, DeVore AD, Anstrom KJ, Eisenstein EL, Fiuzat M, O'Connor CM, Velazquez EJ. Torsemide vs. Furosemide in Heart Failure Patients: Insights from Duke University Hospital Journal of Cardiac Failure. 20. DOI: 10.1016/J.Cardfail.2014.06.267 |
0.594 |
|
| 2014 |
Chen HH, Anstrom KJ, Stevens SR, Deswal A, Felker G, Givertz MM, Bart BA, Wilson Tang W, McNulty SE, Velazquez EJ, Lee KL, Borlaug BA, Shah MR, Hernandez AF, Braunwald E, et al. Differential Response to Low Dose Dopamine or Nesiritide in Patients with Acute Heart Failure and Renal Dysfunction in Accordance to LV EF: Sub-Group Analysis of the ROSE AHF Trial Journal of Cardiac Failure. 20: S94. DOI: 10.1016/J.Cardfail.2014.06.264 |
0.355 |
|
| 2014 |
Testani JM, Stevens SR, Brisco MA, Hernandez AF, Anstrom KJ, Wilson Tang W. Influence of Diuretic Dose and Route of Administration on Loop Diuretic Efficiency: Insights from the Diuretic Optimization Strategies Evaluation in Acute Heart Failure (DOSE-AHF) Trial Journal of Cardiac Failure. 20: S40. DOI: 10.1016/J.Cardfail.2014.06.115 |
0.33 |
|
| 2014 |
Grodin JL, Stevens SR, Fuentes Ldl, Kiernan M, Birati EY, Gupta D, Bart BA, Felker M, Chen HH, Butler J, Dávila-Román VG, Margulies KB, Hernandez A, Anstrom K, Wilson Tang W. A Stepwise Pharmacological Care Algorithm for Cardiorenal Syndrome for Acute Heart Failure: Insights from DOSE-AHF, CARRESS-HF, and ROSE-AHF Journal of Cardiac Failure. 20: S13. DOI: 10.1016/J.Cardfail.2014.06.045 |
0.36 |
|
| 2013 |
Lee JS, Collard HR, Anstrom KJ, Martinez FJ, Noth I, Roberts RS, Yow E, Raghu G. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. The Lancet. Respiratory Medicine. 1: 369-76. PMID 24429201 DOI: 10.1016/S2213-2600(13)70105-X |
0.304 |
|
| 2013 |
Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O'Meara E, Tang WH, et al. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. Jama. 310: 2533-43. PMID 24247300 DOI: 10.1001/Jama.2013.282190 |
0.333 |
|
| 2013 |
Chen HH, AbouEzzeddine OF, Anstrom KJ, Givertz MM, Bart BA, Felker GM, Hernandez AF, Lee KL, Braunwald E, Redfield MM. Targeting the kidney in acute heart failure: can old drugs provide new benefit? Renal Optimization Strategies Evaluation in Acute Heart Failure (ROSE AHF) trial. Circulation. Heart Failure. 6: 1087-94. PMID 24046475 DOI: 10.1161/Circheartfailure.113.000347 |
0.384 |
|
| 2013 |
Hess CN, Rao SV, Kong DF, Aberle LH, Anstrom KJ, Gibson CM, Gilchrist IC, Jacobs AK, Jolly SS, Mehran R, Messenger JC, Newby LK, Waksman R, Krucoff MW. Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women). American Heart Journal. 166: 421-8. PMID 24016489 DOI: 10.1016/J.Ahj.2013.06.013 |
0.336 |
|
| 2013 |
Collard HR, Yow E, Richeldi L, Anstrom KJ, Glazer C, Schwarz M, Zisman DA, Hunninghake G, Chapman J, Olman M, Lubell S, Morrison LD, Steele MP, Haram T, Roman J, et al. Suspected acute exacerbation of idiopathic pulmonary fibrosis as an outcome measure in clinical trials Respiratory Research. 14. PMID 23848435 DOI: 10.1186/1465-9921-14-73 |
0.347 |
|
| 2013 |
Kumar RS, Douglas PS, Peterson ED, Anstrom KJ, Dai D, Brennan JM, Hui PY, Booth ME, Messenger JC, Shaw RE. Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: results in 423 965 patients in the linked National Cardiovascular Data Registry and centers for Medicare & Medicaid services payer databases. Circulation. 127: 1395-403. PMID 23547179 DOI: 10.1161/Circulationaha.113.001437 |
0.37 |
|
| 2013 |
Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, LeWinter MM, Rouleau JL, Bull DA, Mann DL, Deswal A, Stevenson LW, Givertz MM, Ofili EO, O'Connor CM, ... ... Anstrom KJ, et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. Jama. 309: 1268-77. PMID 23478662 DOI: 10.1001/Jama.2013.2024 |
0.356 |
|
| 2013 |
Hess CN, Rao SV, Kong DF, Miller JM, Anstrom KJ, Bertrand OF, Collet JP, Effron MB, Eloff BC, Fadiran EO, Farb A, Gilchrist IC, Holmes DR, Jacobs AK, Kaul P, et al. TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium. American Heart Journal. 165: 344-53.e1. PMID 23453103 DOI: 10.1016/J.Ahj.2012.09.008 |
0.335 |
|
| 2013 |
Willis JM, Edwards R, Anstrom KJ, Johnson FS, Del Fiol G, Kawamoto K, Lapointe NM, Eisenstein EL, Lobach DF. Decision support for evidence-based pharmacotherapy detects adherence problems but does not impact medication use. Studies in Health Technology and Informatics. 183: 116-25. PMID 23388267 DOI: 10.3233/978-1-61499-203-5-116 |
0.327 |
|
| 2013 |
Lobach DF, Kawamoto K, Anstrom KJ, Silvey GM, Willis JM, Johnson FS, Edwards R, Simo J, Phillips P, Crosslin DR, Eisenstein EL. A randomized trial of population-based clinical decision support to manage health and resource use for Medicaid beneficiaries. Journal of Medical Systems. 37: 9922. PMID 23321963 DOI: 10.1007/S10916-012-9922-3 |
0.386 |
|
| 2013 |
Al-Khatib SM, Hellkamp A, Bardy GH, Hammill S, Hall WJ, Mark DB, Anstrom KJ, Curtis J, Al-Khalidi H, Curtis LH, Heidenreich P, Peterson ED, Sanders G, Clapp-Channing N, Lee KL, et al. Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials. Jama. 309: 55-62. PMID 23280225 DOI: 10.1001/Jama.2012.157182 |
0.4 |
|
| 2013 |
Bagai A, Peterson E, Honeycutt E, Effron MB, Stone G, Henry TD, Cohen D, Anstrom K, Wang TY. TCT-149 High On-Treatment Platelet Reactivity among Contemporary Acute Myocardial Infarction Patients Treated with Percutaneous Coronary Intervention: Insights from the TRANSLATE-ACS Study Journal of the American College of Cardiology. 62: B47. DOI: 10.1016/J.Jacc.2013.08.882 |
0.342 |
|
| 2013 |
Wang TY, Zettler M, Effron MB, McCoy L, Anstrom K, Fonarow GC, Messenger JC, Stone G, Cohen D, Henry TD, Peterson E. TCT-2 Comparative Effectiveness of Prasugrel vs. Clopidogrel Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: 30-Day Outcomes from the TRANSLATE-ACS Observational Study Journal of the American College of Cardiology. 62: B1. DOI: 10.1016/J.Jacc.2013.08.729 |
0.401 |
|
| 2012 |
Hillegass WB, Patel MR, Klein LW, Gurm HS, Brennan JM, Anstrom KJ, Dai D, Eisenstein EL, Peterson ED, Messenger JC, Douglas PS. Long-term outcomes of older diabetic patients after percutaneous coronary stenting in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008. Journal of the American College of Cardiology. 60: 2280-9. PMID 23194940 DOI: 10.1016/J.Jacc.2012.08.993 |
0.332 |
|
| 2012 |
Gupta A, Braunwald E, McNulty S, Felker GM, Gilbert EM, Alharethi R, Lee KL, Anstrom KJ, Redfield MM, Goldsmith SR, O'Connor CM, Bull DA, Stehlik J, Litwin SE. Obesity and the response to intensified diuretic treatment in decompensated heart failure: a DOSE trial substudy. Journal of Cardiac Failure. 18: 837-44. PMID 23141856 DOI: 10.1016/J.Cardfail.2012.09.005 |
0.337 |
|
| 2012 |
Bart BA, Goldsmith SR, Lee KL, Givertz MM, O'Connor CM, Bull DA, Redfield MM, Deswal A, Rouleau JL, LeWinter MM, Ofili EO, Stevenson LW, Semigran MJ, Felker GM, Chen HH, ... ... Anstrom KJ, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. The New England Journal of Medicine. 367: 2296-304. PMID 23131078 DOI: 10.1056/Nejmoa1210357 |
0.397 |
|
| 2012 |
Patel MR, Marso SP, Dai D, Anstrom KJ, Shunk KA, Curtus JP, Brennan JM, Sedrakyan A, Messenger JC, Douglas PS. Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005-2008. Jacc. Cardiovascular Interventions. 5: 1054-61. PMID 23078736 DOI: 10.1016/J.Jcin.2012.05.017 |
0.301 |
|
| 2012 |
Anderson ML, Peterson ED, Brennan JM, Rao SV, Dai D, Anstrom KJ, Piana R, Popescu A, Sedrakyan A, Messenger JC, Douglas PS. Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort. Circulation. 126: 2190-9. PMID 22988009 DOI: 10.1161/CIRCULATIONAHA.112.111369 |
0.311 |
|
| 2012 |
Subherwal S, Anstrom KJ, Jones WS, Felker MG, Misra S, Conte MS, Hiatt WR, Patel MR. Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia. American Heart Journal. 164: 277-84. PMID 22980292 DOI: 10.1016/J.Ahj.2012.07.002 |
0.337 |
|
| 2012 |
Swigris JJ, Han M, Vij R, Noth I, Eisenstein EL, Anstrom KJ, Brown KK, Fairclough D. The UCSD shortness of breath questionnaire has longitudinal construct validity in idiopathic pulmonary fibrosis. Respiratory Medicine. 106: 1447-55. PMID 22801586 DOI: 10.1016/J.Rmed.2012.06.018 |
0.329 |
|
| 2012 |
Calvert SB, Kramer JM, Anstrom KJ, Kaltenbach LA, Stafford JA, Allen LaPointe NM. Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial. American Heart Journal. 163: 657-65.e1. PMID 22520532 DOI: 10.1016/J.Ahj.2012.01.019 |
0.312 |
|
| 2012 |
Raghu G, Collard HR, Anstrom KJ, Flaherty KR, Fleming TR, King TE, Martinez FJ, Brown KK. Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. American Journal of Respiratory and Critical Care Medicine. 185: 1044-8. PMID 22505745 DOI: 10.1164/Rccm.201201-0006Pp |
0.35 |
|
| 2012 |
Brennan JM, Dai D, Patel MR, Rao SV, Armstrong EJ, Messenger JC, Curtis JP, Shunk KA, Anstrom KJ, Eisenstein EL, Weintraub WS, Peterson ED, Douglas PS, Hillegass WB. Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008. Journal of the American College of Cardiology. 59: 648-54. PMID 22322080 DOI: 10.1016/J.Jacc.2011.10.883 |
0.316 |
|
| 2012 |
Brennan JM, Peterson ED, Messenger JC, Rumsfeld JS, Weintraub WS, Anstrom KJ, Eisenstein EL, Milford-Beland S, Grau-Sepulveda MV, Booth ME, Dokholyan RS, Douglas PS. Linking the National Cardiovascular Data Registry CathPCI Registry with Medicare claims data: validation of a longitudinal cohort of elderly patients undergoing cardiac catheterization. Circulation. Cardiovascular Quality and Outcomes. 5: 134-40. PMID 22253370 DOI: 10.1161/Circoutcomes.111.963280 |
0.317 |
|
| 2012 |
Wang TY, Masoudi FA, Messenger JC, Shunk KA, Boyle A, Brennan JM, Anderson HV, Anstrom KJ, Dai D, Peterson ED, Douglas PS, Rumsfeld JS. Percutaneous coronary intervention and drug-eluting stent use among patients ≥85 years of age in the United States. Journal of the American College of Cardiology. 59: 105-12. PMID 22222072 DOI: 10.1016/J.Jacc.2011.10.853 |
0.302 |
|
| 2012 |
Eisenstein EL, Kong DF, Cowper PA, Bae JP, Ramaswamy K, Anstrom KJ. Nonfatal myocardial infarction and long-term outcomes in coronary artery disease. American Heart Journal. 163: 95-103. PMID 22172442 DOI: 10.1016/J.Ahj.2011.09.024 |
0.334 |
|
| 2011 |
Chin CT, Wang TY, Anstrom KJ, Zhu B, Maa JF, Messenger JC, Ryan KA, Davidson-Ray L, Zettler M, Effron MB, Mark DB, Peterson ED. Treatment with adenosine diphosphate receptor inhibitors-longitudinal assessment of treatment patterns and events after acute coronary syndrome (TRANSLATE-ACS) study design: expanding the paradigm of longitudinal observational research. American Heart Journal. 162: 844-51. PMID 22093200 DOI: 10.1016/J.Ahj.2011.08.021 |
0.37 |
|
| 2011 |
Felker GM, Lee KL, Bull DA, Redfield MM, Stevenson LW, Goldsmith SR, LeWinter MM, Deswal A, Rouleau JL, Ofili EO, Anstrom KJ, Hernandez AF, McNulty SE, Velazquez EJ, Kfoury AG, et al. Diuretic strategies in patients with acute decompensated heart failure. The New England Journal of Medicine. 364: 797-805. PMID 21366472 DOI: 10.1056/Nejmoa1005419 |
0.406 |
|
| 2011 |
Piccini JP, Al-Khatib SM, Hellkamp AS, Anstrom KJ, Poole JE, Mark DB, Lee KL, Bardy GH. Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Heart Rhythm : the Official Journal of the Heart Rhythm Society. 8: 393-400. PMID 21109025 DOI: 10.1016/J.Hrthm.2010.11.033 |
0.37 |
|
| 2011 |
Hillegass WB, Patel MR, Anstrom KJ, Dai D, Klein LW, Guram HS, Eisenstein EL, Peterson ED, Messenger JC, Douglas PS. ACUTE AND LONG-TERM OUTCOMES IN OLDER DIABETIC PATIENTS RECEIVING A CORONARY STENT: CONTEMPORARY RESULTS IN 405,679 PATIENTS Journal of the American College of Cardiology. 57: E1695. DOI: 10.1016/S0735-1097(11)61695-1 |
0.35 |
|
| 2011 |
Gupta A, Stehlik J, McNulty S, Lee KL, Gilbert EM, Budge D, Anstrom K, Bull DA, Felker GM, Verma DR, Drakos SG, Owan T, O'Connor CM, Litwin SE. DOES OBESITY AFFECT RESPONSE TO TREATMENT IN ACUTE DECOMPENSATED HEART FAILURE? A DIURETIC OPTIMIZATION STRATEGIES EVALUATION (DOSE) TRIAL SUBSTUDY Journal of the American College of Cardiology. 57: E199. DOI: 10.1016/S0735-1097(11)60199-X |
0.344 |
|
| 2011 |
Mark DB, Knight JD, Velazquez EJ, Wasilewski J, Howlett JG, Smith PK, Rajda M, Yadav R, Hamman BL, Malinowski M, Naik A, Rankin G, Harding TM, Drew LA, Desvigne-Nickens P, ... Anstrom KJ, et al. Surgical Treatment of Ischemic Heart Failure Trial Journal of Cardiac Failure. 17: 971-972. DOI: 10.1016/J.Cardfail.2011.10.006 |
0.367 |
|
| 2010 |
Eisenstein EL, Honeycutt EF, Anstrom KJ, Becker RC, Granger CB, Rao SV, Jolicoeur ME, Ohman EM. Economic assessment of thrombocytopenia: CATCH Registry. Journal of Medical Systems. 34: 379-86. PMID 20503623 DOI: 10.1007/S10916-008-9250-9 |
0.305 |
|
| 2010 |
Mark DB, Anstrom KJ, McNulty SE, Flaker GC, Tonkin AM, Smith WM, Toff WD, Dorian P, Clapp-Channing NE, Anderson J, Johnson G, Schron EB, Poole JE, Lee KL, Bardy GH. Quality of life effects of automatic external defibrillators in the home: results from the Home Automatic External Defibrillator Trial (HAT). American Heart Journal. 159: 627-634.e7. PMID 20362722 DOI: 10.1016/J.Ahj.2010.01.013 |
0.335 |
|
| 2010 |
Brinkley J, Tsiatis A, Anstrom KJ. A generalized estimator of the attributable benefit of an optimal treatment regime Biometrics. 66: 512-522. PMID 19508237 DOI: 10.1111/J.1541-0420.2009.01282.X |
0.755 |
|
| 2009 |
Leon MB, Kandzari DE, Eisenstein EL, Anstrom KJ, Mauri L, Cutlip DE, Nikolsky E, O'Shaughnessy C, Overlie PA, Kirtane AJ, McLaurin BT, Solomon SL, Douglas JS, Popma JJ. Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). Jacc. Cardiovascular Interventions. 2: 1208-18. PMID 20129547 DOI: 10.1016/J.Jcin.2009.10.008 |
0.317 |
|
| 2009 |
Eisenstein EL, Leon MB, Kandzari DE, Mauri L, Edwards R, Kong DF, Cowper PA, Anstrom KJ. Long-term clinical and economic analysis of the Endeavor zotarolimus-eluting stent versus the cypher sirolimus-eluting stent: 3-year results from the ENDEAVOR III trial (Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). Jacc. Cardiovascular Interventions. 2: 1199-207. PMID 20129546 DOI: 10.1016/J.Jcin.2009.10.009 |
0.323 |
|
| 2009 |
Eisenstein EL, Wijns W, Fajadet J, Mauri L, Edwards R, Cowper PA, Kong DF, Anstrom KJ. Long-term clinical and economic analysis of the Endeavor drug-eluting stent versus the Driver bare-metal stent: 4-year results from the ENDEAVOR II trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions). Jacc. Cardiovascular Interventions. 2: 1178-87. PMID 20129543 DOI: 10.1016/J.Jcin.2009.10.011 |
0.322 |
|
| 2009 |
Allen LA, Anstrom KJ, Horton JR, Shaw LK, Eisenstein EL, Felker GM. Relationship between anemia and health care costs in heart failure. Journal of Cardiac Failure. 15: 843-9. PMID 19944360 DOI: 10.1016/J.Cardfail.2009.06.435 |
0.388 |
|
| 2009 |
Lopes RD, Ohman EM, Granger CB, Honeycutt EF, Anstrom KJ, Berger PB, Crespo EM, Oliveira GB, Moll S, Moliterno DJ, Abrams CS, Becker RC. Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry). The American Journal of Cardiology. 104: 1285-91. PMID 19840578 DOI: 10.1016/J.Amjcard.2009.06.045 |
0.385 |
|
| 2009 |
Eisenstein EL, Sun JL, Anstrom KJ, DeLong ER, Szczech LA, Mark DB. Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients. Journal of Medical Systems. 33: 287-97. PMID 19697695 DOI: 10.1007/S10916-008-9190-4 |
0.357 |
|
| 2009 |
Jolicoeur EM, Ohman EM, Honeycutt E, Becker RC, Crespo EM, Oliveira GB, Moliterno DJ, Anstrom KJ, Granger CB. Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparin. The American Journal of Cardiology. 104: 292-7. PMID 19576363 DOI: 10.1016/J.Amjcard.2009.03.034 |
0.359 |
|
| 2009 |
Allen LaPointe NM, Zhou Y, Stafford JA, Hernandez AF, Kramer JM, Anstrom KJ. Association Between Mortality and Persistent Use of Beta Blockers and Angiotensin-Converting Enzyme Inhibitors in Patients With Left Ventricular Systolic Dysfunction and Coronary Artery Disease American Journal of Cardiology. 103: 1518-1524. PMID 19463509 DOI: 10.1016/J.Amjcard.2009.01.363 |
0.339 |
|
| 2009 |
Douglas PS, Brennan JM, Anstrom KJ, Sedrakyan A, Eisenstein EL, Haque G, Dai D, Kong DF, Hammill B, Curtis L, Matchar D, Brindis R, Peterson ED. Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry. Journal of the American College of Cardiology. 53: 1629-41. PMID 19406337 DOI: 10.1016/J.Jacc.2009.03.005 |
0.336 |
|
| 2009 |
Mark DB, Knight JD, Velazquez EJ, Howlett JG, Spertus JA, Djokovic LT, Harding TM, Rankin GR, Drew LA, Szygula-Jurkiewicz B, Adlbrecht C, Anstrom KJ. Quality of life and economic outcomes with surgical ventricular reconstruction in ischemic heart failure: results from the Surgical Treatment for Ischemic Heart Failure trial. American Heart Journal. 157: 837-44, 844.e1-3. PMID 19376309 DOI: 10.1016/J.Ahj.2009.03.008 |
0.396 |
|
| 2009 |
Reed SD, Li Y, Anstrom KJ, Schulman KA. Cost effectiveness of ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment Journal of Clinical Oncology. 27: 2185-2191. PMID 19332722 DOI: 10.1200/Jco.2008.19.6352 |
0.331 |
|
| 2009 |
Crespo EM, Oliveira GBF, Honeycutt EF, Becker RC, Berger PB, Moliterno DJ, Anstrom KJ, Abrams CS, Kleiman NS, Moll S, Rice L, Rodgers JE, Steinhubl SR, Tapson VF, Granger CB, et al. Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registry American Heart Journal. 157: 651-657. PMID 19332191 DOI: 10.1016/J.Ahj.2009.01.005 |
0.389 |
|
| 2009 |
Mark DB, Pan W, Clapp-Channing NE, Anstrom KJ, Ross JR, Fox RS, Devlin GP, Martin CE, Adlbrecht C, Cowper PA, Ray LD, Cohen EA, Lamas GA, Hochman JS. Quality of life after late invasive therapy for occluded arteries. The New England Journal of Medicine. 360: 774-83. PMID 19228620 DOI: 10.1056/Nejmoa0805151 |
0.308 |
|
| 2009 |
Eisenstein EL, Sun JL, Anstrom KJ, Stafford JA, Szczech LA, Muhlbaier LH, Mark DB. Do Income Level and Race Influence Survival in Patients Receiving Hemodialysis? American Journal of Medicine. 122: 170-180. PMID 19185093 DOI: 10.1016/J.Amjmed.2008.08.025 |
0.301 |
|
| 2008 |
Kramer JM, Curtis LH, Dupree CS, Pelter D, Hernandez A, Massing M, Anstrom KJ. Comparative effectiveness of β-blockers in elderly patients with heart failure Archives of Internal Medicine. 168: 2422-2428. PMID 19064824 DOI: 10.1001/Archinternmed.2008.511 |
0.395 |
|
| 2008 |
Mark DB, Knight JD, Cowper PA, Davidson-Ray L, Anstrom KJ. Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial. American Heart Journal. 156: 698-705. PMID 18926150 DOI: 10.1016/J.Ahj.2008.05.032 |
0.343 |
|
| 2008 |
Mark DB, Anstrom KJ, Sun JL, Clapp-Channing NE, Tsiatis AA, Davidson-Ray L, Lee KL, Bardy GH. Quality of life with defibrillator therapy or amiodarone in heart failure. The New England Journal of Medicine. 359: 999-1008. PMID 18768943 DOI: 10.1056/Nejmoa0706719 |
0.351 |
|
| 2008 |
Anstrom KJ, Kong DF, Shaw LK, Califf RM, Kramer JM, Peterson ED, Rao SV, Matchar DB, Mark DB, Harrington RA, Eisenstein EL. Long-term clinical outcomes following coronary stenting. Archives of Internal Medicine. 168: 1647-55. PMID 18695078 DOI: 10.1001/Archinte.168.15.1647 |
0.386 |
|
| 2008 |
Eisenstein EL, Sun JL, Anstrom KJ, Stafford JA, Szczech LA, Muhlbaier LH, Mark DB. Re-evaluating the volume-outcome relationship in hemodialysis patients Health Policy. 88: 317-325. PMID 18502534 DOI: 10.1016/J.Healthpol.2008.03.017 |
0.306 |
|
| 2008 |
Konstance RP, Eisenstein EL, Anstrom KJ, Shaw LK, Califf RM, Harrington RA, Matchar DB, Schulman KA, Kong DF. Outcomes of second revascularization procedures after stent implantation. Journal of Medical Systems. 32: 177-86. PMID 18461821 DOI: 10.1007/S10916-007-9120-X |
0.369 |
|
| 2008 |
Reed SD, Anstrom KJ, Li Y, Schulman KA. Updated estimates of survival and cost effectiveness for imatinib versus interferon-α plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia Pharmacoeconomics. 26: 435-446. PMID 18429659 DOI: 10.2165/00019053-200826050-00007 |
0.32 |
|
| 2008 |
Curtis LH, Whellan DJ, Hammill BG, Hernandez AF, Anstrom KJ, Shea AM, Schulman KA. Incidence and prevalence of heart failure in elderly persons, 1994-2003 Archives of Internal Medicine. 168: 418-424. PMID 18299498 DOI: 10.1001/Archinternmed.2007.80 |
0.38 |
|
| 2008 |
Oliveira GBF, Crespo EM, Becker RC, Honeycutt EF, Abrams CS, Anstrom KJ, Berger PB, Davidson-Ray LD, Eisenstein EL, Kleiman NS, Moliterno DJ, Moll S, Rice L, Rodgers JE, Steinhubl SR, et al. Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy Archives of Internal Medicine. 168: 94-102. PMID 18195201 DOI: 10.1001/Archinternmed.2007.65 |
0.346 |
|
| 2008 |
Glickman SW, Anstrom KJ, Lin L, Chandra A, Laskowitz DT, Woods CW, Freeman DH, Kraft M, Beskow LM, Weinfurt KP, Schulman KA, Cairns CB. Challenges in Enrollment of Minority, Pediatric, and Geriatric Patients in Emergency and Acute Care Clinical Research Annals of Emergency Medicine. 51: 775-780.e3. PMID 18191297 DOI: 10.1016/J.Annemergmed.2007.11.002 |
0.368 |
|
| 2007 |
Jollis JG, Roettig ML, Aluko AO, Anstrom KJ, Applegate RJ, Babb JD, Berger PB, Bohle DJ, Fletcher SM, Garvey JL, Hathaway WR, Hoekstra JW, Kelly RV, Maddox WT, Shiber JR, et al. Implementation of a statewide system for coronary reperfusion for ST-segment elevation myocardial infarction. Jama. 298: 2371-80. PMID 17982184 DOI: 10.1001/Jama.298.20.Joc70124 |
0.3 |
|
| 2007 |
Allen LaPointe NM, Governale L, Watkins J, Mulgund J, Anstrom KJ. Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation American Heart Journal. 154: 893-898. PMID 17967595 DOI: 10.1016/J.Ahj.2007.06.035 |
0.322 |
|
| 2007 |
Collard HR, Anstrom KJ, Schwarz MI, Zisman DA. Sildenafil improves walk distance in idiopathic pulmonary fibrosis Chest. 131: 897-899. PMID 17356110 DOI: 10.1378/Chest.06-2101 |
0.309 |
|
| 2007 |
Allen LaPointe NM, Pappas P, Deverka P, Anstrom KJ. Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptions Journal of General Internal Medicine. 22: 98-101. PMID 17351847 DOI: 10.1007/S11606-007-0109-4 |
0.318 |
|
| 2007 |
DePuy V, Anstrom KJ, Castel LD, Schulman KA, Weinfurt KP, Saad F. Effects of skeletal morbidities on longitudinal patient-reported outcomes and survival in patients with metastatic prostate cancer. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 15: 869-76. PMID 17262196 DOI: 10.1016/S1569-9056(06)60149-8 |
0.309 |
|
| 2007 |
Kansagra SM, Curtis LH, Anstrom KJ, Schulman KA. Trends in Operator and Hospital Procedure Volume and Outcomes for Percutaneous Transluminal Coronary Angioplasty, 1996 to 2001 American Journal of Cardiology. 99: 339-343. PMID 17261394 DOI: 10.1016/J.Amjcard.2006.08.037 |
0.359 |
|
| 2007 |
Liao L, Anstrom KJ, Gottdiener JS, Pappas PA, Whellan DJ, Kitzman DW, Aurigemma GP, Mark DB, Schulman KA, Jollis JG. Long-term costs and resource use in elderly participants with congestive heart failure in the Cardiovascular Health Study. American Heart Journal. 153: 245-52. PMID 17239685 DOI: 10.1016/J.Ahj.2006.11.010 |
0.34 |
|
| 2006 |
Kramer JM, Hammill B, Anstrom KJ, Fetterolf D, Snyder R, Charde JP, Hoffman BS, Allen LaPointe N, Peterson E. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. American Heart Journal. 152: 454.e1-8. PMID 16923412 DOI: 10.1016/J.Ahj.2006.02.030 |
0.342 |
|
| 2006 |
Mark DB, Nelson CL, Anstrom KJ, Al-Khatib SM, Tsiatis AA, Cowper PA, Clapp-Channing NE, Davidson-Ray L, Poole JE, Johnson G, Anderson J, Lee KL, Bardy GH. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Circulation. 114: 135-42. PMID 16818817 DOI: 10.1161/Circulationaha.105.581884 |
0.374 |
|
| 2006 |
Liao L, Jollis JG, Anstrom KJ, Whellan DJ, Kitzman DW, Aurigemma GP, Mark DB, Schulman KA, Gottdiener JS. Costs for heart failure with normal vs reduced ejection fraction. Archives of Internal Medicine. 166: 112-8. PMID 16401819 DOI: 10.1001/Archinte.166.1.112 |
0.348 |
|
| 2006 |
Reed SD, Anstrom KJ, Li Y, Schulman KA. Updated Cost-Effectiveness Analysis of First-Line Imatinib Compared to Interferon-α in Patients with Newly Diagnosed Chronic Myeloid Leukemia in the Chronic Phase Using 60-Month Data from IRIS. Blood. 108: 3312-3312. DOI: 10.1182/Blood.V108.11.3312.3312 |
0.315 |
|
| 2006 |
Green T, Labelle G, Steele P, Lee L, Mankad V, Williams L, Anstrom K, Burks A. Clinical Characteristics of Patients with Peanut Allergy Journal of Allergy and Clinical Immunology. 117: S35. DOI: 10.1016/J.Jaci.2005.12.142 |
0.328 |
|
| 2005 |
Cabell CH, Abrutyn E, Fowler VG, Hoen B, Miro JM, Corey GR, Olaison L, Pappas P, Anstrom KJ, Stafford JA, Eykyn S, Habib G, Mestres CA, Wang A. Use of surgery in patients with native valve infective endocarditis: Results from the International Collaboration on Endocarditis Merged Database American Heart Journal. 150: 1092-1098. PMID 16291004 DOI: 10.1016/J.Ahj.2005.03.057 |
0.317 |
|
| 2005 |
Wang A, Pappas P, Anstrom KJ, Abrutyn E, Fowler VG, Hoen B, Miro JM, Corey GR, Olaison L, Stafford JA, Mestres CA, Cabell CH. The use and effect of surgical therapy for prosthetic valve infective endocarditis: A propensity analysis of a multicenter, international cohort American Heart Journal. 150: 1086-1091. PMID 16291003 DOI: 10.1016/J.Ahj.2005.01.023 |
0.362 |
|
| 2005 |
Ohman ME, Granger CB, Rice L, Abrams CS, Becker RC, Berger PB, Kleiman NS, Moliterno D, Moll S, Rodgers JE, Steinhubl SS, Tapson VF, Sinnaeve P, Anstrom KJ. Identification, diagnosis and treatment of heparin-induced thrombocytopenia and thrombosis: A registry of prolonged heparin use and thrombocytopenia among hospitalized patients with and without cardiovascular disease. The complication after thrombocytopenia caused by heparin (CATCH) registry steering commitee Journal of Thrombosis and Thrombolysis. 19: 11-19. PMID 15976962 DOI: 10.1007/S11239-005-0850-7 |
0.399 |
|
| 2005 |
Al-Khatib SM, Anstrom KJ, Eisenstein EL, Peterson ED, Jollis JG, Mark DB, Li Y, O'Connor CM, Shaw LK, Califf RM. Clinical and economic implications of the multicenter automatic defibrillator implantation trial-II Annals of Internal Medicine. 142: 593-600. PMID 15838065 DOI: 10.7326/0003-4819-142-8-200504190-00007 |
0.324 |
|
| 2005 |
Reed SD, Friedman JY, Engemann JJ, Griffiths RI, Anstrom KJ, Kaye KS, Stryjewski ME, Szczech LA, Reller LB, Corey GR, Schulman KA, Fowler VG. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia Infection Control and Hospital Epidemiology. 26: 175-183. PMID 15756889 DOI: 10.1086/502523 |
0.352 |
|
| 2004 |
Chu VH, Cabell CH, Abrutyn E, Corey GR, Hoen B, Miro JM, Olaison L, Stryjewski ME, Pappas P, Anstrom KJ, Eykyn S, Habib G, Benito N, Fowler VG. Native valve endocarditis due to coagulase-negative staphylococci: Report of 99 episodes from the International Collaboration on Endocarditis Merged Database Clinical Infectious Diseases. 39: 1527-1530. PMID 15546091 DOI: 10.1086/424878 |
0.355 |
|
| 2004 |
Reed SD, Anstrom KJ, Ludmer JA, Glendenning GA, Schulman KA. Cost-effectiveness of imatinib versus interferon-α plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia Cancer. 101: 2574-2583. PMID 15493042 DOI: 10.1002/Cncr.20694 |
0.309 |
|
| 2004 |
Liao L, Cabell CH, Jollis JG, Velazquez EJ, Smith WT, Anstrom KJ, Pappas PA, Ryan T, Kisslo JA, Landolfo CK. Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left ventricular dysfunction undergoing revascularization. The American Journal of Cardiology. 93: 1275-9. PMID 15135703 DOI: 10.1016/J.Amjcard.2004.01.071 |
0.356 |
|
| 2004 |
Guller U, Anstrom KJ, Holman WL, Allman RM, Sansom M, Peterson ED. Outcomes of early extubation after bypass surgery in the elderly Annals of Thoracic Surgery. 77: 781-788. PMID 14992871 DOI: 10.1016/J.Athoracsur.2003.09.059 |
0.388 |
|
| 2004 |
Cabell CH, Trichon BH, Velazquez EJ, Dumesnil JG, Anstrom KJ, Ryan T, Miller AB, Belkin RN, Cropp AB, O'Connor CM, Jollis JG. Importance of echocardiography in patients with severe nonischemic heart failure: The Second Prospective Randomized Amlodipine Survival Evaluation (PRAISE-2) Echocardiographic Study American Heart Journal. 147: 151-157. PMID 14691434 DOI: 10.1016/J.Ahj.2003.07.010 |
0.395 |
|
| 2004 |
Moll S, Abrams CS, Rice L, Becker RC, Berger PB, Anstrom KJ, Honeycutt EF, Crespo EM, Granger C, Moliterno DJ, Rodgers JE, Steinhubl SR, Tapson VF, Ohman M. Thrombocytopenia Is More Common and Nadir Occurs Earlier with Unfractionated Heparin Than with Low Molecular Weight Heparin - Results from the Prospective Catch Registry. Blood. 104: 2197-2197. DOI: 10.1182/Blood.V104.11.2197.2197 |
0.318 |
|
| 2004 |
Crespo EM, Becker RC, Berger PB, Granger CB, Kleinman NS, Moliterno DJ, Moll S, Rice L, Abrams CS, Rogers J, Steinhubl SS, Tapson VF, Anstrom KJ, Ohman E. 1123-180 Incidence and evaluation of heparin-induced thrombocytopenia (HIT) among patients treated with prolonged heparin and among thrombocytopenic patients in the cardiac care unit: Preliminary results of the CATCH registry Journal of the American College of Cardiology. 43: A501. DOI: 10.1016/S0735-1097(04)92119-5 |
0.341 |
|
| 2003 |
Trichon BH, Glower DD, Shaw LK, Cabell CH, Anstrom KJ, Michael Felker G, O'Connor CM. Survival after coronary revascularization, with and without mitral valve surgery, in patients with ischemic mitral regurgitation Circulation. 108: II103-II110. PMID 12970217 DOI: 10.1161/01.Cir.0000087656.10829.Df |
0.392 |
|
| 2003 |
McGuire DK, Anstrom KJ, Peterson ED. Influence of the Bypass Angioplasty Revascularization Investigation National Heart, Lung, and Blood Institute Diabetic Clinical Alert on practice patterns: Results from the National Cardiovascular Network database Circulation. 107: 1864-1870. PMID 12668513 DOI: 10.1161/01.Cir.0000064901.21619.01 |
0.337 |
|
| 2003 |
Al-Khatib SM, Li Y, Anstrom K, Peterson E, Jollis J, O'Connor C, Lee KL, Shaw L, Califf RM. Are the results of the multicenter automatic defibrillator implantation trial-II applicable to patients seen at a tertiary referral center? Journal of the American College of Cardiology. 41: 96. DOI: 10.1016/S0735-1097(03)81030-6 |
0.31 |
|
| 2002 |
Eisenstein EL, Shaw LK, Nelson CL, Anstrom KJ, Hakim Z, Mark DB. Obesity and long-term clinical and economic outcomes in coronary artery disease patients. Obesity Research. 10: 83-91. PMID 11836453 DOI: 10.1038/Oby.2002.14 |
0.343 |
|
| 2001 |
Peterson ED, Lansky AJ, Kramer J, Anstrom K, Lanzilotta MJ. Effect of gender on the outcomes of contemporary percutaneous coronary intervention. The American Journal of Cardiology. 88: 359-64. PMID 11545754 DOI: 10.1016/S0002-9149(01)01679-4 |
0.321 |
|
| 2001 |
Eisenstein EL, Shaw LK, Anstrom KJ, Nelson CL, Hakim Z, Hasselblad V, Mark DB. Assessing the clinical and economic burden of coronary artery disease: 1986-1998. Medical Care. 39: 824-35. PMID 11468501 DOI: 10.1097/00005650-200108000-00008 |
0.322 |
|
| 2001 |
Holman WL, Allman RM, Sansom M, Kiefe CI, Peterson ED, Anstrom KJ, Sankey SS, Hubbard SG, Sherrill RG. Alabama coronary artery bypass grafting project: Results of a statewide quality improvement initiative Journal of the American Medical Association. 285: 3003-3010. PMID 11410099 DOI: 10.1001/Jama.285.23.3003 |
0.347 |
|
| 2001 |
Mast ST, Gersing KR, Anstrom KJ, Krishnan KR, Califf RM, Jollis JG. Association between selective serotonin-reuptake inhibitor therapy and heart valve regurgitation American Journal of Cardiology. 87: 989-993. PMID 11305992 DOI: 10.1016/S0002-9149(01)01435-7 |
0.382 |
|
| 2001 |
Mast ST, Jollis JG, Ryan T, Anstrom KJ, Crary JL. The progression of fenfluramine-associated valvular heart disease assessed by echocardiography Annals of Internal Medicine. 134: 261-266+1. PMID 11182835 DOI: 10.1016/S1062-1458(01)00309-9 |
0.369 |
|
| 2000 |
Batchelor WB, Anstrom KJ, Muhlbaier LH, Grosswald R, Weintraub WS, O'Neill WW, Peterson ED. Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: Results in 7,472 octogenarians Journal of the American College of Cardiology. 36: 723-730. PMID 10987591 DOI: 10.1016/S0735-1097(00)00777-4 |
0.387 |
|
| 2000 |
Alexander KP, Anstrom KJ, Muhlbaier LH, Grosswald RD, Smith PK, Jones RH, Peterson ED. Outcomes of cardiac surgery in patients age ≥80 years: Results from the national cardiovascular network Journal of the American College of Cardiology. 35: 731-738. PMID 10716477 DOI: 10.1016/S0735-1097(99)00606-3 |
0.362 |
|
| 2000 |
Peterson ED, Lansky AJ, Anstrom KJ, Muhlbaier LH, Popma JJ, Satler LF, Lanzilotta MJ. Evolving trends in interventional device use and outcomes: Results from the National Cardiovascular Network Database American Heart Journal. 139: 198-207. PMID 10650291 DOI: 10.1016/S0002-8703(00)90226-6 |
0.351 |
|
| Show low-probability matches. |